retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A MAJOR POSITIVE DEVELOPMENT FOR THE COMPANY
""Kontrol" or "Company"), is pleased to announce that the Ontario government is providing $2 million to CEM Specialties Inc. ("CEMSI"), a London based subsidiary of Kontrol Technologies Corp., through the Ontario Together Fund to help commercialize and accelerate production of Kontrol BioCloudTM, a COVID-19 detector.
"From day one, Ontario unleashed its innovation and manufacturing might in the fight against COVID-19, with businesses rolling out new innovations and products to help keep the frontlines and the general public safe," said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. "It's the creativity and ingenuity of enterprising companies like CEMSI, with its innovative COVID-19 detection technology, that will help Ontario and the rest of the world successfully emerge from this pandemic, while creating hundreds of good jobs for our province's skilled workers."
Kontrol BioCloud ("BioCloudTM"), developed by CEMSI, is a made-in-Ontario real-time COVID-19 detection device that continuously monitors the presence of the SARS-COV-2 virus in the air. The technology promotes air circulation, monitors air quality and samples continuously for pathogens like viruses, bacteria and fungi. When the presence of the virus is detected, BioCloud provides an alert in the cloud or over a local intranet. The Company has received all approvals required to commercialize and produce the technology. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com
With Ontario's support, CEMSI plans to increase production capacity to 20,000 units per month. The product will be manufactured in London with more than 85 per cent of its components produced in province. The company anticipates accelerating the production of the BioCloud will create up to 250 direct jobs and up to 750 indirect jobs
"We want to thank the Ontario government for their support for commercializing and accelerating production of BioCloud," says Paul Ghezzi, CEO of Kontrol Technologies Corp. "Our CEMSI team has been focused on developing a solution to create safer spaces through the real-time monitoring of SARS-CoV-2. BioCloud seeks to provide an early detection mechanism with a silent alerting system. Just as smoke detectors and carbon monoxide detectors are now part of building safety, we have created BioCloud as an innovative viral detection technology to help get the economy and daily life back closer to normal. BioCloud is a complement and support to the province's vaccination rollout, rapid testing and contract tracing and can be located in schools, offices, places of worship, long-term care homes, hospitals and much more. We are proud to be a made-in Ontario technology and we are very pleased to be hiring and creating new jobs."
The investment funding agreement with government requires Kontrol to achieve certain production milestones and the investment funding will be issued in two tranches of $1.2 Million immediately and $800,000 on completion of the milestones by March 30th 2021. The agreement was executed on January 27th 2021 with a condition precedent of non-disclosure until February 4th, 2021.
Through the Ontario Together Fund, the government is delivering targeted investments that will increase the province's stockpile of made-in-Ontario products and PPE. This new innovative technology and manufacturing capacity will help the province to combat the current COVID-19 outbreak and prepare for potential challenges in the future, while supporting local businesses during the safe and gradual reopening of the province.
About Kontrol BioCloudTM
BioCloud is a real-time analyzer designed to detect airborne viruses. It operates as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.
BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate or cure the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Tradem"
PEGASUS INCREASES LAND HOLDINGS AND LISTS THE REVENUE FRON SALES OF PROJECTS. PROBABLY8 RAISED ENOUGH MONEY FOR EXPLORATION OF PROJECTS STILL HELD.
"Pegasus Resources Inc. (TSX-V: PEGA; Frankfurt – OQS2, OTC/Pink Sheet symbol SLTFF) (the “Company” or “Pegasus”) is pleased to provide an update of Company activities on various projects, including recently received results from field work at the Gold Mountain and Vertebrae Ridge properties, (part of the Golden Project), the sale of some of the Company’s Confederation Lake properties to Trillium Gold Mines Inc., and the option of certain properties to Infinite Ore Corp.
Based on encouraging early stage surface sample results from two parallel trends of copper-silver mineralization at Vertebrae Ridge, the Company recently staked additional mineral tenures both north and south of the original property to cover potential extensions to the known mineralization. With the addition of these two new mineral tenures, the Company has increased its land holdings from 2,871 ha to 5,324 ha (7,091.95 acres to 13,155.70 acres). The Company is currently planning for a late Spring 2021 work program.
VERTEBRAE RIDGE
The Vertebrae Ridge property is comprised of four claims totaling 5,323.9 ha (13,155.7 acres) approximately 81 km northwesterly from Golden, British Columbia. A prospecting program during fall 2020 resulted in the discovery and identification of significant polymetallic mineralization at multiple locations, including:
Zone 1
18 rock samples collected over a 1,400+ metre strike with sample assays of 4.13% Cu, 28.6% Pb, 4.74% Zn, and 360 g/t Ag;
Exhibits anomalous concentrations of As, Hg and Sb, in addition to Cu, Pb, Zn and Ag;
Zone 2 North
13 rock samples collected over a 650+ metre strike returned an arithmetic average of 2.5% Cu and 4.5 g/t Ag, with peak values of 10.7% Cu and 29.1 g/t Ag; and
Vein 160 Showing
7 rock samples collected over an approximate 250 metre strike returned an arithmetic average of 10.5% Cu and 14.7 g/t Ag, with peak values of 35.5% Cu and 96.7 g/t Ag.
GOLD MOUNTAIN
The Gold Mountain property is located just north of Highway 1, about 50 km northwesterly from Golden, British Columbia. An exploration program carried out during fall 2020 at the Gold Mountain property confirmed and identified the following:
Polymetallic mineralization over 600 to 700 metre strike;
High grades of silver/gold with 4 samples returning from 1,000 to 6,670 g/t Ag ; and
Gold samples up to 7.44 g/t.
Eight shallow back pack style drill holes were completed in 1984, though poor recoveries were noted, results include:
4.04 m - 59.04 g/t Au, 6,863.1 g/t Ag, 16.9% Cu, and 8.95% Pb
4.50 m - 7.89 g/t Au, 942.2 g/t Ag, 2.3% Cu, and 5.26% Pb
TRILLIUM ASSET SALE
The sale of some of the Company’s Confederation Lake properties to Trillium Gold Mines Inc. (TGM-V) for consideration of $500,000 in cash and Trillium Gold Mines’ common shares valued at $1,250,000 was accepted by the TSX Venture Exchange on December 15, 2020. The remaining payments of $400,000 cash and $1,250,000 of Trillium Gold Mines’ common shares payable to Pegasus are expected shortly.
PROPERTIES OPTIONED TO INFINITE ORE CORP. (“ILI-V)
The Company has three properties optioned out to ILI-V. The cumulative outstanding payments and work commitments due to Pegasus by ILI-V are as follows:
$325,000 cash
5,250,000 ILI-V common shares
$3,050,000 work commitment
About Pegasus Resources Inc.
Pegasus Resources Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on zinc and base metal properties in North America."
4
A MAJOR REVENUE SOURCE RECEIVES APPROVAL FOR PORTUGAL/EUROPEAN DISTRIBUTION!
" (“Flowr” or the “Company”) provides commentary on the decision by INFARMED, I.P. (“INFARMED”), Portugal’s National Authority of Medicines and Health Products, to approve the first market authorization which will allow a licensed producer of medical cannabis to release products in Portugal.
“We applaud the decision by INFARMED, which was the first of its kind, to allow patients to have access to medical cannabis products in Portugal through indication-specific market authorizations. The Portuguese government is forward thinking in its approach to improving the quality of life for Portuguese patients as scientific data continues to mount regarding medical cannabis as both safe and efficacious in treating a variety of conditions,” commented Pauric Duffy, Flowr’s Managing Director of Europe. “This ground-breaking decision sets the stage for Flowr to pursue market authorizations to serve Portuguese and European patients with medical cannabis produced from our world class local facilities in Sintra and Aljustrel,” commented Lance Emanuel, President and Interim CEO of Flowr.
In March 2020, Flowr announced that its wholly-owned subsidiary in Europe, Holigen Holdings Limited (“Holigen”), received its Good Manufacturing Practice (GMP) certification in accordance with European Union standards, for its indoor manufacturing facility located in Sintra, Portugal. The GMP certification was issued by INFARMED. Holigen is in the process of conducting stability testing on certain of its high-THC genetics and expects results within 2021.
Located just outside of Lisbon, Holigen’s Sintra facility is a purpose-built facility with six grow rooms, a research and development lab and an expected extraction processing facility. The Sintra facility is capable of producing approximately 2,000 kilograms of premium dried flower when fully optimized. Holigen’s European operations also include the Aljustrel facility which has more than 5,000,000 square feet of outdoor grow space and greenhouse capacity, capable of producing in excess of 500,000 kilograms of cannabis when fully operational.
About The Flowr Corporation
The Flowr Corporation is a Toronto-headquartered cannabis company with operations in Canada, Europe, and Australia. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility. From this campus, Flowr produces recreational and medicinal products. Internationally, Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in both Portugal and Australia.
Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products."
[A FULL REPORT BY MANAGEMENT OF THE GOLD AND MINERAL PROJECTS OF GLM.
THEY ARE STILL WAITING FOR THE ASSAYS DRILLED IN THE FALL.
"GOLDEN LAKE REPORTS 303 G/T SILVER AND 11.2 G/T GOLD FROM SURFACE GRAB SAMPLES AT THE SOUTH EUREKA ZONE, JEWEL RIDGE PROPERTY, NEVADA
Golden Lake Exploration Inc. has released additional anomalous and significant silver and gold values from surface rock samples from several targets on the company's keystone Jewel Ridge gold property located near the town of Eureka, Nev.
"While we await assays from three diamond drill holes completed in November, the company is very encouraged to identify additional areas of widespread silver and gold mineralization over the Jewel Ridge property. The company is looking forward to an aggressive and expansive drill program (RC and core) in 2021 to define and expand the targets outlined in 2020 and to test the new targets identified by rock and soil geochemistry, magnetics and induce polarization geophysics, and structural mapping," stated Mike England, chief executive officer of Golden Lake.
Northeast Eureka target
The area northeast of the Eureka Tunnel portal was drilled by the company with five drill holes (four reverse circulation (RC) holes and one core hole (assays pending)). Highlights included RC hole JR-20-06 which intersected two zones of mineralization. An upper mineralized zone (UMZ) of 1.25 grams gold per tonne (g/t) gold (Au) and 5.5 g/t silver (Ag) over 16.76 metres was intersected from surface and a second, lower mineralized zone was intersected at a depth of 160 metres, averaging 1.48 g/t Au and 1.3 g/t Ag over 10.67 metres, hosted in dolomite. Similar to the UMZ, the lower-grade mineralization (halo mineralization) underlies this interval, with a wider zone returning 0.83 g/t Au and one g/t Ag over 21.34 metres from a depth of 160.02 metres. Hole RC-20-09 was the only hole on the east flank of the valley that was drilled to depth (190 metres) to test this mineralized horizon (holes RC-20-06, 07 and 08 were too shallow). The multiple stacked nature of the oxide gold mineralized horizons significantly enhances the tonnage potential of the Northeast Eureka zone in hole JR-20-09.
Surface sampling was conducted northeast of the company's drill holes, in an area of intense road building and shallow, historic drill holes over an area of 200 metres in a northeast direction by 160 metres wide. Many samples were retrieved from piles around historic RC holes that the company does not have data for. The results strongly indicate a continuation of the Northeast Eureka zone to the north and northeast. Silver and base metals values are markedly lower on samples from this target area and are interpreted to reflect Carlin-style, oxide gold mineralization. Additional sampling will be conducted with drilling to follow.
South Eureka target
The South Eureka target is centred approximately 230 metres due south of the Eureka Tunnel adit in a north-south-trending steeply incised valley. Diamond drill hole JR-20-DD13 (assays pending) tested this target. Four rock samples of highly oxidized, gossanous material from dumps and workings in the area have returned good gold, silver and base metal values indicative of carbonate replacement deposit (CRD) mineralization. The area is located just southwest of, and on trend with, the Northeast Eureka zone.
Hamburg mine target
The Hamburg mine target is located in the south-central portion of the Jewel Ridge property and represents both Carlin-type and CRD-type oxide gold mineralization hosted in the Hamburg dolomite at or near the contact with the Dunderberg shale. Three angled reverse circulation holes, comprising 548.64 metres, were completed by the company in 2020 with the best intercept in RC hole JR-20-02 of 0.936 g/t Au over 16.76 metres from a depth of 152.4 metres in the recent program. Significantly, holes JR-20-02 and JR-20-03 both intersected wide intercepts of anomalous gold values (defined as greater than 0.1 g/t Au). Hole JR-20-02 intersected 0.436 g/t Au over 57.91 metres from a depth of 123.44 metres and hole JR-20-03 returned 0.161 g/t Au over 106.7 metres from 73.2 metres. A total of seven rocks samples were collected north and northwest of the area drilled by the company to investigate determine the extent and style of the gold mineralization. All samples, except J-32, were in areas previously unsampled and no known drilling. These recent rock results are encouraging and indicate excellent potential for gold mineralization to continue to the northwest of the historic Hamburg mine and open pit. A program of soil geochemistry is proposed when weather permits to better define the gold mineralization followed by drilling.
West Eureka (Industry Tunnel mine) target
The West Eureka target is located on the west flank of the valley, approximately 200 metres southwest of the Eureka Tunnel adit. The target covers portions of the historic Industry Tunnel mine with extensive workings and dumps and no known drill holes. Many samples are extensively oxidized and the higher silver and associated base metals are characteristic of CRD mineralization.
While grab rock samples are not representative of the grade of mineralization of an occurrence or target, they are useful in determining prospectivity and geological features. The rock samples in an attached table were delivered by the company consulting geologist to the ALS prep facility in Elko, Nev. All samples are analyzed for copper, gold, silver and 31 other elements. Gold is determined by ALS method Au-AA23, which is a fire assay with an atomic absorption spectroscopy finish on a 30-gram split. Copper, silver and the remaining 31 elements are determined by ALS method ME-ICP61, which is a four-acid digestion and inductively coupled plasma atomic emission spectroscopy assay. Golden Lake is reliant on ALS Labs in Reno, Nev., for its quality assurance/quality control (QA/QC) protocol as these are preliminary samples and limited in number.
The company is awaiting assay results from three diamond drill core holes completed in November on the Eureka Tunnel area. Drilling on the Jewel Ridge property during 2020 comprised 10 RC holes (5,200 feet (1,585 metres)) and three diamond drill holes (1,236 feet (376.6 metres)). Planning is in progress for a spring 2021 drill program on multiple target areas on federal (BLM) and patented lands, with EM Strategies of Reno, Nev., engaged to lead the permitting process.
Drilling quality assurance and quality control statement
Procedures have been implemented to assure QA/QC of drill hole assaying is being done at an ISO accredited assay laboratory. All intervals of drill holes are being assayed and samples have been securely shipped and received by ALS Labs in Reno, Nev., with chain-of-custody documentation through delivery. Mineralized commercial reference standards and coarse blank standards are inserted every 20th sample in sequence. All results will be analyzed for consistency. Assays are pending and will be reported when available.
About the Jewel Ridge property
The Jewel Ridge property is located on the south end of Nevada's prolific Battle Mountain-Eureka trend, along strike and contiguous to Barrick Gold's Archimedes/Ruby Hill gold mine to the north and Timberline Resources' advanced-stage Lookout Mountain project to the south.
The property comprises 96 unpatented lode mining claims and 30 patented claims covering approximately 728 hectares (1,800 acres). The Jewel Ridge property contains several historic small gold mines. The company's focus is on Carlin-style disseminated gold deposits, the primary focus in the area since the late 1970s.
Nevada Carlin-type gold deposits (CTGD) have a combined endowment of more than 250 million ounces, which are concentrated (85 per cent) in only four trends or camps of deposits -- Carlin, Cortez (Battle Mountain-Eureka), Getchell and Jerritt Canyon. The company cautions thatresults on adjacent and/or nearby projects are not necessarily indicative of results on the company's property. /b]
MANAGEMENT IS ADDING PERSONS TO THEIR ADVISORY BOARD. PART TIME FOR NOW AS THEY OBVIOUSLY FEEL THERE IS A MARKET FOR THEIR PRODUCTS THAT CAN BE EXPANDED AND DEVELOPED.THEY ARE BUILDING AN INCLUSIVE AND INTELLIGENT COMPANY
"("PLAN" or the "Company"), is pleased to announce the appointment of Brian Sheppard and Nicole Stefenelli to the company's Advisory Board, and Dr. Chad Vecitis to its research team.
Progressive Planet Solutions (CNW Group/Progressive Planet Solutions)
'These appointments are a major step forward for Progressive Planet' says CEO, Stephen Harpur. 'Brian, Nicole and Chad are leaders in their respective fields, and each bring outstanding expertise that will help us guide the Company through its next stage of growth.' These appointments are part-time in nature, and each of the appointees remain in their existing roles with their current employers.
Sheppard will advise on marketing and communication efforts. He has over 25 years of experience at Canada's leading advertising agencies, working on many of the country's most powerful brands. Sheppard is currently the Executive Creative Director of Saatchi & Saatchi Canada. In addition to creating effective, award-wining advertising, he is also an instructor in the Advertising faculty of the Ontario College of Art & Design (OCADU) in Toronto.
Stefenelli will advise on procurement of commercial amounts of post-consumer glass and other commodities required for the commercialization of PozGlass SCM. She is CEO and Founder of Urban Impact Recycling, a well-established recycling company serving customers in British Columbia's Lower Mainland. Stefenelli brings three decades of experience in the field of finding solutions to the growing problem of corporate and institutional waste. In 2010 she won the Ernst & Young CEO of the Year in the Cleantech category. In 2012 she was awarded the YWCA Women of Distinction Award in the Entrepreneur category. Stefenelli served on the Board of Directors for the Forum for Women Entrepreneurs and Science World and has also served on the Board of the Recycling Council of British Columbia.
Dr. Vecitis has been contracted to provide expertise and guidance in regard to carbon sequestration in cellular concrete. Dr. Vecitis is the CTO and Co-Founder of Nth Cycle that is redefining the metal supply chain by developing novel metallurgic technologies. He is also an Associate of Environmental Science & Engineering at the Harvard Paulson School of Engineering & Applied Sciences where his research focuses on environmental science and emerging nanotechnologies. Dr. Vecitis is co-author of over eighty peer-reviewed papers and a number of patents, and has been invited to present his research around the world.
ABOUT PROGRESSIVE PLANET
Progressive Planet is an emerging leader in supplying solutions for a livable planet by developing low carbon, pozzolan-based, cementing products which replace equivalent amounts of Portland Cement and fly ash in concrete. The production of Portland Cement is the second largest global generator of CO2 emissions.
Progressive Planet operates its flagship Z1 Natural Pozzolan Quarry in Cache Creek, British Columbia and is earning a 100% interest in the Z2 Natural Pozzolan Property near Falkland, BC and earning a 100% interest in the Heffley Creek Metals and Natural Pozzolan Property. All three properties are within a one-hour drive of Kamloops, BC, an industrial hub with rail access to Canadian and US markets.}"
TODAYS NEWS JUSTIFIES A SIGNIFICANTLY HIGHER PRICED SHARE LEVEL!
"("Voyager" or the "Company") (CSE: VYGR) (OTCQB: VYGVF) (FRA: UCD2), a publicly-traded, licensed crypto-asset broker that provides investors with a turnkey solution to trade crypto assets, today announced that the Voyager Digital App was downloaded a record 250,000 times during the three-day period ended January 31, 2021, with the Voyager app reaching a high of #18 in the App Store rankings in the United States on Friday, January 29, 2021. In addition, the Company announced that the Voyager App processed over 1 million trades during the month of January 2021, compared with 200,000 trades that were processed in December 2020.
"We are extremely excited by this rapid influx of new customers we've experienced in such a short timeframe," said Steve Ehrlich, Co-founder and CEO of Voyager Digital. "To support this growth, we are constantly enhancing our systems and will continue to onboard consumers in a very judicious manner, to ensure every user gets the very best Voyager experience."
}
THAT DIDN'T TAKE LONG-PP COMPLETED
The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced Dec. 22, 2020, and Jan. 7, 2021.
Number of shares:7.5 million shares Purchase price:10 cents per share Warrants:7.5 million share purchase warrants to purchase 7.5 million shares Warrant exercise price:15 cents for a one-year period Number of placees:29 placeesInsiders:Countryman Investments Ltd. (George Richardson), one million; The Howard Group (Grant Howard), 350,000Total pro group involvement:350,000 (two placees) Finders' fees:Mackie Research Capital Corp., $7,500 cash and 75,000 broker warrants payable; PI Financial Corp., $7,500 cash and 75,000 broker warrants payable; Canaccord Genuity Corp., $12,750 cash and 127,500 broker warrants payable (Each broker warrant is exercisable into one common share at 10 cents for one year from closing.)
MR. RICHARDSON HAS A HUGE POSITION IN THE SHARES OF THE
COMPANY AND DESERVES IT. WITHOUT HIS INVESTMENT I DON'T THINK THE COMPANY WOULD HAVE THE OPPORTUNITY IT HAS. IF SALES OF THEIR PRODUCTS ARE AS BENEFICIAL TO THE ENVIRONMENT WE COULD SEE MULTIPLES OF THE SHARE PRICE.
IE WATCH THE REVENUE FLOWS IN THE FINANCIALS TO DETERMINE THE FUTURE SHARE PRICES.
LOOKS LIKE RHT HAS DEVELOPED A VASTLY MORE USEFULL "APPLE" LIKE WRIST WATCH FOR SENIOR PATIENTS.
If successful would be a significant revenue flow for the company y and a very useful aid for patient care.
"(“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that the Company has signed its first contract to deploy its proprietary iUGO Home solution.
The iUGO Home solution uses a wearable Personal Emergency Response System (PERS) device - a watch or pendant - to connect patients to their care team using two-way communication, sensors and automated alerts. iUGO Home uses the wearable PERS device to provide:
Fall detection with automated alerts to the patient’s care team
Medication reminders for the patient
Two-way audio communication
Automated geofencing-based alerts to the care team or family members if a patient wanders outside a defined area
The PERS device can connect to the iUGO Cloud via WiFi or cellular, and acts as a hub to wirelessly connect to any Bluetooth-enabled biometric devices the patient is using.
“We are very excited to have signed our first contract to deploy our iUGO Home product,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “iUGO Home is a highly scalable solution that was designed to support patients in their own homes or in residential care settings such as long term care, skilled nursing and hospice facilities. Using iUGO Home allows facility staff to receive alerts if a patient falls, is in distress or attempts to leave the facility, and with two way communication staff can speak to patients to instantly triage the patient and provide reassurance. In the home, our solution supports seniors who are aging in place, giving family members and care providers the comfort of knowing that if their loved one or patient wanders or suffers a fall or other medical emergency, they will receive an immediate alert and will have the ability to speak directly to the patient to assess the situation."
The Company has signed a new contract with a long term care facility in North Texas to provide iUGO Home to their patients. The client will go live next month, and the Company expects to add 3,000 iUGO Home patients in North Texas by the end of the year. iUGO Home represents a new revenue stream for the Company, with average revenues per patient of $30 USD/patient/month, Many of these patients will also be using other iUGO Care products including Remote Patient Monitoring, Chronic Care Management, Transitional Care Management and Behavioral Health Integration, with an average additional revenue per patient of $40 USD/patient/month.
About Reliq Health
Reliq Health Technologies is a rapidly growing global telemedicine that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits."
MANAGEMENT IS PROVING SUCCESSFUL in obtaining rights to significant lithium deposits in Northern Ontario. while drilling must be completed
to confirm 43-101 compliance, work already performed has been encouraging.
"Infinite Ore Corp. (the "Company") (TSXV:ILI)(OTCQB:ARXRF) is pleased to announce the acquisition of four additional lithium claims in Ontario having a historic resource of 750,000 tons yielding 1.38% Li2O*. This is in addition to the historical resource of 2 million tons at 1.09% Li2O* currently present on the Jackpot property. The new claims are contiguous to, and located within, the Company's Jackpot Property (see Figure 1). The claims contain the Newkirk-Vegan lithium showing that was discovered through exploration in the 1950's. Drilling at the time traced the Newkirk dike for 609 meters with an average thickness of 5 m.Figure 1: Location of acquired claims shown in yellow.J.C. St-Amour, President of Infinite Ore commented, "This property acquisition adds to our existing historical resources of 2,000,000 tons grading 1.09% Li2O*. We are pleased to be able to provide our shareholders exposure to lithium, gold and base metals exploration through our Jackpot and Eastern Vision properties."The Company's 100% owned Jackpot Lithium project is located in close proximity to the Georgia Lake lithium deposit, for which Rock Tech Lithium Inc. recently announced its intent to develop a lithium sulphate production facility located in Thunder Bay, Ontario.Infinite Ore acquired the claims through payments to an arms-length party of $10,000 cash and 300,000 common shares. The vendor retains a royalty of 1.0% on revenue generated from non-smelter elements from the Jackpot Claims and a 1.0% NSR. This may be purchased at any time for $500,000.00.Qualified PersonThe technical content of this news release was approved by Michel Boily, PhD, P.Geo, an Independent Qualified Person as defined by the National Instrument 43-101.* The estimates presented above are treated as historic information and have not been verified or relied upon for economic evaluation by the Company. These historical mineral resources do not refer to any category of sections 1.2 and 1.3 of the NI-43-101 Instrument such as mineral resources or mineral reserves as stated in the 2010 CIM Definition Standards on Mineral Resources and Mineral Reserves. The explanation lies in the inability by the Company to verify the data acquired by the various historical drilling campaigns. The Company as not done sufficient work yet to classify the historical estimates as current mineral resources or mineral reserves.About Infinite Ore Corp.Infinite Ore is a junior mining exploration company focused on seeking and acquiring world-class mineral projects. The company is earning into a large land package with the potential for VMS and gold mineralization in the Confederation Lake assemblage belt near Red Lake, Ont. The company also holds the Jackpot lithium property located near Nipigon, "
FINALLY FOUND THE RIGHT BOARD! hAVE BEEN POSTING ON WRONG ONE.
TODAYS NEWS confirms the company continues to establish significant aids for trading.
Usio, Inc. (Nasdaq: USIO), an integrated electronic payment solutions provider, announced today that its strategic partnership with leading crypto currency broker Voyager Digital Holdings, LLC (“Voyager”) has been renewed and expanded wherein Usio will now become Voyager’s exclusive provider of ACH payment solutions.
Louis Hoch, President and Chief Executive Officer of Usio, said, “We are pleased to expand our partnership with Voyager, which was initially signed in 2018. We are also extremely excited to have been chosen as the exclusive provider of their ACH electronic payment needs. Over the past few years we have supported Voyager’s meteoric growth with a wide breadth of payment facilitation technology that enables them to provide their clients both the flexibility and extended capabilities that can make transactions within the crypto-asset trading framework seamless and transparent. The exciting and fast-growing crypto markets represent a tremendous growth opportunity where our increasing expertise and comprehensive electronic payment solutions are proving to be of great value to this rapidly emerging market. Due to the strong interest in the cryptocurrency markets, our activity with Voyager is quickly on the rise, and we look forward to supporting what they expect to be another year of strong growth.”
Steve Ehrlich, Co-founder and CEO of Voyager, noted, “Since the beginning, our partnership with Usio has been beneficial for both of us. Given our exponential growth, we’re glad we selected a company with a complete range of products and services we can access. Our development team is also very happy with the knowledge and responsiveness of the Usio staff. Voyager continues to grow and we rely on great partnerships such as Usio to provide us with the technology and scalability we can be confident in as we expand.”
About Voyager Digital Holdings, LLC
Voyager Digital Holdings, LLC, an operating subsidiary of Voyager Digital Ltd. (CSE: VYGR) (OTCQB: VYGVF) (FRA: UCD2), is a crypto-asset broker that provides retail and institutional investors with a turnkey solution to trade crypto assets. Voyager offers investors best execution, data and custody services through its institutional-grade open architecture platform. Voyager was founded by established Wall Street and Silicon Valley entrepreneurs who teamed to bring a better, more transparent and cost-efficient alternative for trading crypto-assets to the marketplace.
About Usio, Inc.
Usio, Inc. (Nasdaq: USIO), a leading integrated payment solutions provider, offers a wide range of payment solutions to merchants, billers, banks, service bureaus, and card issuers. The Company operates credit, debit/prepaid, and ACH payment processing platforms to deliver convenient, world-class payment solutions and services to their clients. The strength of the Company lies in its ability to provide tailored solutions for card issuance, payment acceptance, and bill payments as well as its unique technology in the prepaid sector. Usio is headquartered in San Antonio, Texas,"
MANAGEMEN SHOWS THEY HAVE PLANS FOR THEIR DEVELOPMENT OF SIGNIFICANT PSILOCYBIN PRODUCTION. ENCOURAGING THAT THEY ARE QUICKLY MOVING FORWARD.
" (the "Company") is pleased to announce its wholly-owned subsidiary Vocan Biotechnologies Inc. ("Vocan") has assembled the necessary equipment, which will allow the laboratory to commence the process of recombinant production of psilocybin. The process that engineers bacteria incorporating optimized biosynthetic genes from the Psilocybe cubensis mushroom, will enable the bacteria to act as a biological factory and synthesize psilocybin that is cost effective using simple building blocks.Vocan's platform can make the active compounds that occur naturally, by using a gene mimicry process and simple chemical modifications to enable the creation of bioidentical compounds as well as known and novel analogs. The analog compounds could prove to be more effective, targeted and safer.Vocan has now received and assembled equipment required to move forward on its plan to produce biosynthesized psilocybin. Due to the cost and long lead times, this is a critical milestone in the company's plan. The equipment enables Vocan to improve on the current work being conducted in the lab and puts Vocan ahead of schedule on its plan to begin the recombinant production of psilocybin."Vocan's recombinant production of psilocybin is a significant improvement over the current methods of psilocybin production. Reducing both the cost and time needed to produce and purify psilocybin to only a few days, compared to much longer and more expensive methods for whole mushroom extraction. Having the equipment purchased and assembled positions Vocan to execute on its objectives in the short term." Stated Joel Shacker CEO of the Company.Further to the Company's press release dated January 15, 2021 announcing the closing of its sale of non-core assets, the Company wishes to correct that it has issued a total of 500,000 common shares as an administrative fee to three arms-length third-parties who assisted with facilitating such sale, not 350,000 shares to two parties, as previously announced.About Core One Labs Inc. Core One Labs Inc. is a biotechnology research and development company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The Company has developed a patent pending thin film oral strip (the "technology") which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining excellent bioavailability. With this technology, the Company intends to further develop its IP technology to focus on delivering psychedelic molecules with an initial focus on biosynthesized psilocybin. Core One also holds an interest in walk-in medical clinics which maintain a database of over 200,000 patients combined. Through research and development in these clinics, including the integration of its intellectual property related to psychedelic treatments and novel drug therapies, the Company intends to work towards regulatory approval for research that advances psychedelic-derived treatments for mental health disorders.Core One Labs Inc.Joel ShackerChief Executive OfficerCautionary
Disclaimer Statement: The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information. In addition, psilocybin is currently a Schedule III drug under the Controlled Drugs and Substances Act (Canada) and it is a criminal offence to possess substances under the Controlled Drugs and Substances Act (Canada) without a prescription. Health Canada has not approved psilocybin as a drug for any indication. Core One Labs Inc. does not have any direct or indirect involvement with illegal selling, production, or distribution of psychedelic substances in jurisdictions in which it operates. While Core One Labs Inc. believes psychedelic substances can be used to treat certain medical conditions, it does not advocate for the legalization of psychedelics substances for recreational use. Core One Labs Inc. does not deal with psychedelic substances, except within laboratory and clinical trial settings conducted within approved regulatory frameworks.
Company announces new technology improvements and first contract obtained for its use. Keep on innovating
(“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced the launch of its new multilingual Interactive Voice Recognition product, iUGO Care IVR, and a new contract with a physician practice in Maryland to use iUGO Care IVR with both their English- and Russian-speaking patients.
“We have incorporated Interactive Voice Recognition (IVR) in the iUGO Care platform to support patients who are using their own, non-connected monitoring devices, have cellular or internet connectivity challenges or simply prefer an automated daily phone call in the language of their choice as a reminder to collect their vitals,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “The new product uses Interactive Voice Recognition to communicate with patients in any language, record patients’ self-reported readings and automatically upload the data to the iUGO Care platform, where it can be accessed by their care team. This solution is of particular interest to private insurers and employer-sponsored insurance plans who want patients to use their existing, non-connected biometric monitoring devices. Clinicians can also leverage existing Medicare reimbursement codes for Remote Patient Monitoring involving self-reported data. This is a highly scalable product that will allow us to serve a large patient population that was not previously addressed by standard Remote Patient Monitoring technology."
The Company has signed a new contract with a physician practice in Maryland to provide Remote Patient Monitoring with Interactive Voice Recognition to a significant Russian-speaking patient population. Onboarding started in Maryland this week. The Company expects to expand the IVR product offering into additional geographies requiring a variety of different languages later this quarter."
.
MANAGEMENT presents update for BioCloud. Shows areas it is trying to develop. In this market order numbers are the only thing that will move the share price. Takes time.
" ("Kontrol" or "Company"), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce that it continues to advance the deployment of its BioCloud technology.
"We are pleased with the progress we are making with our distribution network, our direct customers and various levels of Government," says Paul Ghezzi, CEO. "Through our growing distribution network, we have been presented with numerous potential customers applications. Most recently we have reviewed various applications for professional and amateur sports."
Non-Disclosure Agreement (NDA)
BioCloud has entered into a Non-Disclosure Agreement, with a leading medical sports authority, to share the full scope of BioCloud's patents and research. The purpose of the NDA is to advance various potential sport applications. Such applications include, but are not limited to, dressing rooms and training facilities.
BioCloud European Standards
Kontrol has initiated the CE standards approval process and BioCloud now has the appropriate power supply ratings for European applications, which is an important prerequisite for European sales. As part of the product requirements for each country within the European Union there may be further standards approval required but these will be dealt with on a case-by-case basis.
Distribution Network
Kontrol has recently added a South Korean firm to its growing distribution network and is in discussion with numerous interested parties.
Viral/Pathogen Advisory Committee
Kontrol is in the process of establishing a viral/pathogen advisory committee that will work with management to accelerate various BioCloud applications. Kontrol seeks to establish the committee in February 2021.
Corporate Name Change
Kontrol's corporate name change to Kontrol Technologies Corp. is anticipated to be completed by the end of January 2021. There has been no specific delay in the process other than the time it takes to complete filings between B.C. and Ontario corporate registries and all of the associated requirements.
About Kontrol BioCloudTM
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others."
AND THE COMPANY CONTINUES GROWTH AVAILABLE FOR TRADING
OF PRODUCTS
"Voyager Digital Ltd. has listed the Terra (Luna) token on the Voyager platform, expanding Voyager's industry-leading offering to 57 digital assets.
"By adding the Luna token to the Voyager platform, our U.S. customers will now have one of the first direct fiat-to-crypto onramps available on mobile devices," said Steve Ehrlich, co-founder and chief executive officer of Voyager. "Our commission-free agency broker platform is quickly becoming the most trusted and transparent vehicle for investors to buy, trade and hold digital assets. We will continue to enhance our customer-centric platform with additional offerings including debit and credit cards, margin, and the listing of other digital assets."
Terra Luna is a next-generation smart contract platform and programmable money for the internet. Terra's platform supports stable coins that offer instant settlements, low fees and seamless cross-border exchange, and are loved by millions of users and merchants.
"Both Terra and Voyager are making crypto and blockchain more accessible for mainstream adoption," added Terra co-founder and chief executive officer, Do Kwon. "Terra's focus on merchant and payment adoption will be pushing the future forward on blockchain-powered digital payments. We're excited to be partnered with Voyager, availing the power of Luna to the masses."
About Voyager Digital Ltd.
Voyager Digital is a crypto-asset broker that provides retail and institutional investors with a turnkey solution to trade crypto assets. Voyager offers customers best execution and safe custody on a wide choice of popular crypto assets. Voyager was founded by established Wall Street and Silicon Valley entrepreneurs who teamed up to bring a better, more-transparent and cost-efficient alternative for trading crypto assets to the marketplace.}
MANAGEMENT COMPLETES EXPANSION RE LITHIUM AND ACQUISITIONS RE GOLD,MINERALS. The start of exploration and drilling in these areas should begin very soon.
" Infinite Ore Corp. (the "Company") (TSXV:ILI)(OTCQB:ARXRF) is pleased to announce that it has added to its Jackpot Lithium project holdings through the acquisition of a 100% interest in 9 claims. The claims are contiguous to and located within the Company's Jackpot Property (see Figure 1). The Company's 100% owned Jackpot Lithium project is located in close proximity to the Georgia Lake lithium deposit, for which Rock Tech Lithium Inc. recently announced its intent to develop a lithium sulphate production facility located in Thunder Bay, Ontario
J.C. St-Amour, President of Infinite Ore commented, "This property acquisition enhances our land position in a burgeoning lithium camp. We are pleased to be able to provide our shareholders with exposure to lithium, gold and base metals exploration through our Jackpot and Eastern Vision properties."
The acquired claims are known to contain lithium showings based on historical work, including the M.N.W. dyke*. The claims contain lithium showings based on historical work including a pegmatite dyke that ranges in thickness up to 14 m and has been traced intermittently for 427 m. The core of the dyke was sampled in 1956 and was found to average 1.5% Li2O over a 122 m strike having widths up to 9 m.
Infinite Ore acquired the claims through payments to an arms-length party of $10,000 cash and 300,000 common shares. The vendor retains a royalty of 1.0% on revenue generated from non-smelter elements from the Jackpot Claims and a 1.0% NSR. This may be purchased at any time for $500,000.00.
Closing of Eastern Vision Claim Acquisition
The Company is also pleased to announce that, further to its press release of January 6, 2021, the company has closed the acquisition of 100% in 7 minerals claims located within its Eastern Vision project. Infinite Ore acquired the claims through payments to an arms-length party of $7,500 cash and 100,000 common shares. The vendor retains a 1.5% Net Smelter Royalty which can be bought back for $1.5 million at any time.
Qualified Person
The technical content of this news release was approved by Michel Boily, PhD, P.Geo, an Independent Qualified Person as defined by the National Instrument 43-101.
*Reference: Pye, E.G. (1965) Geology and Lithium Deposits of Georgia Lake Area, p. 84.
About Infinite Ore Corp.
Infinite Ore is a junior mining exploration company focused on seeking and acquiring world-class mineral projects. The company is earning into a large land package with the potential for VMS and gold mineralization in the Confederation Lake assemblage belt near Red Lake, Ont. The company also holds the Jackpot lithium property located near Nipigon, Ont."
.
TODAYS NEWS ANNOUNCES ANOTHER REVENUE SOURCE FOR THE COMPANY. $150,000.A REVENUE PARTNERSHIP IS PART OF THE DEAL AS WELL
"("ImagineAR") and KABN Systems NA Holdings Corp. (CSE:KABN / OTC:TRW (the "Company", "KABN North America" or "KABN NA"), are excited to announce the execution of a three-year $150,000 SDK licensing agreement to launch Augmented Reality ("AR") immersive experiences integrated with Liquid Avatar (www.liquidavatar.com). Liquid Avatar empowers user to manage, control and gain value from their biometrically verified Self Sovereign Identity and personal data ownership.
Using ImagineAR's licensed AR SDK and cloud-based studio suite, KABN will deliver a series of dynamic AR interactions to Liquid Avatar mobile app users starting in early 2021. Liquid Avatar users will experience immersive consumer AR-based social, event, educational and information-based messages. Commercial enterprises and media companies will present dynamic measurable interactive AR offers to Liquid Avatar users knowing the consumer is real and verified thereby significantly reducing marketing waste and breakage. The range of opportunities are potentially limitless as Liquid Avatar's Self Sovereign Identity platform is addressable to up to 100% of all online users.
Liquid Avatar users will soon be able to create and share interactive 3D greetings and messages that are automatically integrated with their Liquid Avatar icons and can be experienced inside the Liquid Avatar app. Liquid Avatar users will also be able to share AR enabled resumes, invitations, event programs, and other information with their social connections. Additionally, Liquid Avatar is exploring interactive digital wallets, which will allow users to easily visualize all their in-wallet verifiable access and identity credentials, like those for healthcare, gaming, travel, financial services, education, ecommerce, and government services.
"Augmented Reality provides a new way to see the world around us and allows KABN to empower Liquid Avatar's known and verified users to take advantage of this interactive technology to engage with friends, family, and other connections," said David Lucatch, CEO KABN. "ImagineAR's platform provides immersive experiences and an effective way for us to instantly deliver AR opportunities to our constituents, therefore creating revenue and value opportunities for our expanding user base."
Exploring other partnership programs, KABN NA and ImagineAR will enable commercial enterprises and media companies to create and deliver fully immersive AR experiences, allowing users to have a 3D view of products and services, whether they are shopping online, or visiting a specific geo-location like a shop, restaurant, etc. Movie trailers, in-shopping and music videos, online concert and other media productions, menus, schedules, podcasts and other items can "come alive" online or right at the location, along with any special bonuses, rewards, offerings and incentives.
For the travel industry, users can review immersive experiences directly from printed materials, on locations, venues and resorts. The education and information services sector can create and deliver interactive engagement opportunities to convey information and choices.
"We are thrilled to partner with KABN to provide our AR expertise, knowledge and products to their Liquid Avatar users," says Alen Paul Silverrstieen, Founder and CEO of ImagineAR. "KABN's programs provide engagement with known and verified users, creating the type of value our clients are looking for, and our multi-year agreement allows us to quickly ramp up our programs and create long-term value for our stakeholders."
A MAJOR ACHIEVEMENT BY THE COMPANY!! DELIVERY OF SIGNIFICANTLY CONTROLED PSILOCYBIN IS A MAJOR BREAKTHROUGH FOR MENTAL HEALTH TREATMENT!!THIS SHOULD GIVE GREAT CREDIBILITY TO THE COMPANY.
"Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method
VANCOUVER, BC / ACCESSWIRE / January 12, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company") is pleased to announce its plans to initiate another intellectual property strategy that will utilize its patented transmucosal thinstrip delivery method ("thinstrip delivery method") in combination with its proprietary biosynthetic psilocybin, developed by its wholly-owned subsidiary, Vocan Biotechnologies Inc. ("Vocan").
The Company's existing thinstrip delivery method has been patented for use with THC and CBD (CannaStripsTM) and has the potential for use with all naturally occurring compounds, including psilocybin
Through cutting-edge research by the Company's team at Vocan, a cost effective method for producing biosynthesized psilocybin has been developed. This low cost method of psilocybin production, in combination with the incorporation of psilocybin into the Company's thinstrip technology, will result in an innovative and first-to-market delivery method of psilocybin for medical purposes.
Core One's objective in developing the psilocybin thinstrips is to assist with the delivery of revolutionary psychedelic treatment methods to address mental health conditions such as depression, anxiety and addictions.
Methods of accurate dosing and effective delivery of psilocybin have gone relatively under-researched, and current methods utilized by companies using traditional oral delivery methods can cause hallucinations, digestive issues, and inaccurate dosages resulting in undesired side effects. The Company's patented sublingual transmucosal (orally dissolvable) thinstrip technology, for the delivery of psilocybin, will aim to address these issues, and anticipates the provision of many potential advantages and benefits such as the rapid dissolving and onset of action to the bloodstream, as well as concentration control and time released dosing. Thinstrip delivery technology is a natural, non-toxic, biodegradable, biocompatible composite, which is user friendly. The sublingual polymer thinstrip, with nano particulated active ingredients, skips the digestive system and is absorbed directly into the bloodstream through the membranes in the mouth, resulting in optimum bioavailability (absorption percentage) of the active ingredients. Direct delivery to the bloodstream means that dosages can be less potent with the same affect.
According to the World Health Organization, almost 350 million people worldwide were affected by depression in 2016. Common antidepressant drugs help maintain the balance of various hormones and chemicals in the brain which assists in the treatment of depression.
The Center for Disease Control and Prevention (CDC), reported that the percentage of people above the age of 12 years using antidepressants in the U.S. rose 12.7% in 2011-2014. According to MedGadget, the antidepressant drug market was valued at $13.69 billion in 2018 and is expected to reach $15.88 billion by 2025. The CDC said that in the U.S., antidepressants were the most commonly prescribed drugs in 2013 and from over 16 million long term users, around 70% are female.
"One of the critical issues surrounding the use of psilocybin is accurate dosing in oral delivery methods. Our breakthrough technology is a game changer in the psychedelic space and has the potential to revolutionize the way patients receive psychedelics as medicine and reduce over concentrations and resulting adverse effects." stated Dr. Robert E.W. Hancock, Executive Chairman of the Company.
About Core One Labs Inc.
Core One Labs Inc. is a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The Company has developed a patent pending thin film oral strip (the "technology") which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining excellent bioavailability. With this technology, the Company intends to further develop its technology to focus on delivering psychedelic molecules with an initial focus on psilocybin. Core One also holds an interest in walk-in medical clinics which maintain a database of over 200,000 patients combined. Through research and development in these clinics, including the integration of its intellectual property related to psychedelic treatments and novel drug therapies, the Company intends to work towards regulatory approval for research that advances psychedelic-derived treatments for mental health disorders."
MANAGEMENT OF ILI HAVE CHOSEN THE CONFEDERATION NORTH AREA OF RED LAKE AS A MAJOR AREA TO EXPLORE FOR GOLD, SILVER AND COPPER.
The major exploration will begin in the coming months. This will be a critically important project for the future of the company.
As always wait for the assays of the drilling to be confident as to the values. Visuals can be deceiving. Keep everything crossed in hopes of success.
"Infinite Ore Corp. (the "Company") (TSXV:ILI)(OTCQB:ARXRF) is pleased to announce that it has identified multiple potential gold, copper and silver anomalies from its Spaciotemporal Geochemical Hydrocarbon ("SGH") survey conducted on a portion of its Confederation North property. SGH surveys have been used successfully in the Red Lake area to locate gold anomalies under till cover, most notably by Great Bear Resources Ltd. at the LP Fault, Dixie Limb, and Hinge zones on their Dixie property.
Results from the 443-sample survey indicate the covered area contains at least two gold anomalies accompanied by copper and silver anomalies that are potential targets for drilling (see Figures 1 to 4). The anomalies are located immediately to the north of gold showings and SGH gold anomalies reported by Portofino Resources Inc. Actlabs, who analyzed the survey, describes the SGH survey as a procedure that provides a highly focused and sensitive method which measures organic compounds in the C5-C17 range in concentrations down to the low parts-per-trillion (ppt) onto near surface samples, in this case tills. The analysis can detect signatures associated with the presence of buried mineralized bodies such as orogenic gold and VMS.
JC St-Amour, President of Infinite Ore, commented: "We are pleased that the results of the SGH survey has provided gold, silver and copper anomalies that may constitute drill targets. The presence of gold anomalies detected by a SGH survey conducted by Portofino Resources and tied to significant gold values in bedrock showings increase our confidence in the current survey. Infinite Ore plans on using the results of both the SGH survey and the new VTEM survey to identify major structures on the property and to add targets to our drill program scheduled to begin in the coming weeks.
The company's VTEM survey on its red Lake properties has resumed and is approximately 40% complete, with results expected in late January. More information will be released in the coming weeks."
WE ARE ALIVE!!
ALMOST LIKE A REAL COMPANY-AGAIN
"CannTrust Holdings Inc. ("CannTrust" or the "Company") announces it is re-entering the Canadian medical cannabis market today with its new medical brand estoraTM and will begin serving patients immediately.
CannTrust Logo (CNW Group/CannTrust Holdings Inc.)
estoraTM builds on CannTrust's foundation of consistent, high quality products, with a focus on providing superior patient care in every interaction, connecting patients, health care practitioners and partners with the educational resources and products they need to navigate each patient's unique medical cannabis journey.
"Since our inception, we have been dedicated to providing Canadians with consistently high-quality medical cannabis," said Greg Guyatt, Chief Executive Officer at CannTrust. "We're delighted to be launching our new medical brand estoraTM with a portfolio of medical cannabis products including oil drops, capsules and dr
"We believe it was imperative to evolve our strong foundation in medical cannabis to meet the changing needs of our patients," said Guyatt. "estora™ has patient care at its core. We consulted patients and health care practitioners, learning more about their needs and refining our processes and product offerings to elevate their experience with us."
CannTrust remains under CCAA protection to facilitate its efforts to resolve its civil litigation claims and complete its review of strategic alternatives. These efforts are ongoing and confidential, and the Company is unable to predict either their timing or their outcome. In the meantime, with the reinstatement of its cannabis licenses and the ongoing restoration of its operations, CannTrust's re-entry into the medical cannabis business segment is an important part of its focus on rebuilding trust by delivering quality, innovative products to its patients and customers.
About estoraTM
estoraTM is a Canadian medical cannabis brand. Our portfolio has been designed with patients in mind, with easy-to-use formats and standardized processes, that ensure consistency and quality in every bottle. We're not just a medical cannabis provider, but a partner, providing guidance and support for our patients on their journey with medical cannabis, so they can focus on what's really important. "
Management attempting to reach more USA exposure. Can't hurt.
"(“Reliq” or the “Company”), a rapidly growing digital health company that develops innovative Virtual Care software as a service (SaaS) solutions for the Community Healthcare market has retained Lytham Partners, LLC ("Lytham Partners") to lead a U.S. investor relations program.
For more than 20 years, Lytham Partners has been one of the industry’s leading investor relations firms in the U.S., having created one of the largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications.
“We made significant progress in 2020 in the United States by increasing our penetration beyond our historical markets of Florida and South Texas,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “We are now working with clients across the U.S. and have a clear path to cashflow positive in Q1 2021. Given our recent progress and anticipated growth in 2021, we believe that this is an opportune time to increase awareness of our company within the U.S. investment community. We look forward to working with the team at Lytham Partners, which has a strong understanding of the healthcare technology space and a proven track record of helping public companies communicate their story to the largest and most relevant cross section of institutional investors."
Ben Shamsian, Vice President of Lytham Partners, said, "Given Reliq’s fast growing and diversified customer base across the United States, we believe the U.S. investment community will be interested to learn more about their unique value proposition and opportunities ahead to create value for shareholders. We look forward to introducing the Company to our platform of investors while keeping shareholders apprised of the developments taking place at the Company."
In connection with the engagement, Lytham Partners will be compensated USD $6,000 per month.
The Company also announces the granting of stock options under its Stock Option Plan to purchase an aggregate of 500,000 common shares of the Company at an exercise price of $0.415 per share for a five year term. The stock options were granted to the CFO of the Company pursuant to Reliq’s Stock Option Plan and the policies of the TSX Venture Exchange and vest over one year.
About Lytham Partners
For more than 20 years, Lytham Partners has been one of the country's leading investor relations firms, having created one of the industry's largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with many of the industry's most respected institutional investors, Lytham Partners has spent the past two decades creating an integrated platform that allows its clients far reaching exposure to investors in a consistent and in-depth format. This platform is matched with a communications and positioning approach that is streamlined throughout press releases, conference calls, investor presentations, corporate profiles, and websites"
INTERESTING REPORT BY PEGASUS GIVES ILI SHAREHOLDERS SUMMARY OF OUR HOLDINGS IN THE CONFEDERATION AREA.
Pegasus optioned properties to Infinite Ore Corp. (“ILI”)
A.Dixie 17-20 (Dixie 10 Mile)
A VTEM airborne survey is presently underway on this property. A geochemical survey was previously completed and the Company is awaiting assays results.
The properties total 1072 hectares, 35 km southeast of Red Lake and about 18 km from Great Bear Resources.
A mineralized zone on Dixie 17 yielded results up to 7.34 Zn and 1.4% Cu over a core length of 9.5 metres. On Dixie 18, a mineralized zone has been drilled over a core length of 250 metres and to a depth of 150 meters. Dixie 19 zone has been traced over a length of 500 metres, with drill intercepts including 6.33% Zn and 1.5% Cu over a core length of 355 metres.
These properties are 90% optioned to Infinite Ore Corp with the following outstanding payments and work commitment due:
$30,000 cash, 500,000 ILI shares and $550,000 work commitment
B. Garnet Lake
This is a 2733 hectares land package including a substantial mineral deposit and a number of mineralized drill intersections that are in need of follow-up drill testing. Mineralization on the property is all Volcanogenic Massive Sulphides (VMS) type, dominated by zinc, copper and silver with associated gold values. (see NR Oct 10, 2016)
A 2100 line km VTEM PlusTM airborne survey was completed in 2017 detected parallel conductors or extensions of known conductors in lengths of 400, 850, 900 and 950 metres at Fredart Corridor which is within a total strike length of 22km.
This property has an NI43-101 resource of:
3% Zn equiv. cutoff
Indicated Res. 2,071,000 tonnes @ 5.92% Zn, 0.75% Cu, 21.1 g/t Ag and 0.58 g/t Au
Inferred Res 120,550 tonnes @ 2.60% Zn, 0.56% Cu, 18.6 g/t Ag and 0.40 g/t Au
5% Zn equiv. cutoff
Indicated Res. 1,762,000 tonnes @ 6.75% Zn, 0.79% Cu, 22.3 g/t Ag and 0.61 g/t Au
Inferred Res. 51,630 tonnes @ 3.86% Zn, 0.79% Cu, 23.9 g/t Ag and 0.58 g/t Au
10% Zn equiv. cutoff
Indicated Res 633,000 tonnes @ 14.3 Zn, 1.11% Cu, 31.7 g/t Ag and 0.85 g/t Au
This land package is 80% optioned to Infinite Ore Corp with the following outstanding payments and work commitment due:
$225,000 cash, 3,000,000 ILI shares and $1,550,000 work commitment
C. Fredart
The Fredart Property had 124 drill holes completed between 1956 and 2003, totaling 22,500 metres. This deposit has a historical mineral resource of 425,000 tonnes grading 1.56% copper. This historical resource estimate does not comply with the standards of NI 43-101 and has not been reviewed by a Qualified Person. The zone was drill-tested to a depth of approximately 200 metres over a length of 350 metres, and was reported as being open at depth. Only portions of the drill holes were assayed for gold, due to the low price of gold at the time. The area was also explored for molybdenum in the 1970s, and samples containing up to 1.46% Mo were reported.
This property is 80% optioned to Infinite Ore Corp with the following outstanding payments and work commitment due:
$70,000 cash, 1,750,000 ILI shares and $1,000,000 work commitment.
The company changed its name from Pistol Bay Mining Inc. to Pegasus Resources Inc. effective December 23, 2020. Our new symbol is TSX-V-PEGA and CUSIP number is 70558T105.
Management moving forward on winter exploration plans.
Hopefully will provide some significant results towards gold finds.
Infinite Ore Corp. (the "Company") (TSXV:ILI)(OTCQB:ARXRF) is pleased to announce that it has added to its Easter Vision holdings through the acquisition of a 100% interest in 7 claims. The claims are contiguous to and located within the Company's Confederation North Property (see Figure 1). Confederation North is located on the Birch-Uchi greenstone belt approximately 40 km east of the town of Red Lake Ontario and 20 km East of Great Bear Resources Ltd.'s Dixie p
In addition, the Company has completed a Spaciotemporal Geochemical Hydrocarbon ("SGH") survey on a portion of its Confederation North property and a VTEM survey on the property is approximately 38% complete and is expected to resume this week, with results expected in January. The Company plans to incorporate relevant information from both surveys to add gold targets to its VMS targets for the upcoming winter drill program. Results of the analysis will be released in the coming weeks.
Infinite Ore acquired the claims through payments to an arms-length party of $7,000 cash and 100,000 common shares. The vendor retains a 1.5% Net Smelter Royalty which can be bought back for $1.5 million at any time.
Qualified Person
The technical content of this news release was approved by Michel Boily, PhD, P.Geo, an Independent Qualified Person as defined by the National Instrument 43-101.
About Infinite Ore Corp.
Infinite Ore is a junior mining exploration company focused on seeking and acquiring world-class mineral projects. The company is earning into a large land package with the potential for VMS and gold mineralization in the Confederation Lake assemblage belt near Red Lake, Ont. The company also holds the Jackpot lithium property located near Nipigon, Ont.
LOOKS TO ME FLWR HAS FINALLY REACH A STAGE IN DEVELOPMENT
THAT RAISES THE COMPANY TO SIGNIFICANT DEVELOPMENT FOR THE FUTURE. KELONA IS COMPLETE. PORTUGAL KS COMPLETE. PRODUCTION WILL BEING SIGNIFICANT REVENUE FLOWS AND HE BUILDING SESSIONS ARE COMPLETE.
TODAYS NEWS SHOWS SIGNIFICANT RESEARCH COMPETENCE IS AVAILABLE.
"Mr. Lance Emanuel reports
FLOWR AND HAWTHORNE CANADA JOINTLY ANNOUNCE THE COMPLETION OF THE WORLD'S FIRST CANNABIS RESEARCH AND DEVELOPMENT FACILITY OF ITS KIND
North America's first research and development facility dedicated to advancing cannabis cultivation techniques and systems has been completed by The Flowr Corp. and Hawthorne Canada Ltd. Hawthorne is a subsidiary of the Hawthorne Gardening Company division of The Scotts Miracle-Gro Company (NYSE:SMG). Scotts Miracle-Gro is the world's leading marketer of branded consumer lawn and garden products and indoor growing solutions. Flowr cultivates and sells premium cannabis to medical and adult-use markets in Canada, Europe and Australia.
Located on Flowr's cultivation campus in Kelowna, British Columbia, Canada, the R&D Center includes state-of-the-art laboratories, indoor grow suites, and training areas in a single building. Flowr will test cultivation systems and techniques using Hawthorne's advanced lighting, fertilization and irrigation systems, growing mediums, and research protocols. In addition, Flowr intends to focus its own research on cannabis genetics and integrated growing systems in line with its goal of delivering premium quality cannabis products through highly efficient cultivation.
"We built Hawthorne to help cultivators of all sizes grow quality plants with high levels of efficiency and consistency. Completing the industry's only dedicated R&D facility gives us a distinct advantage. We will leverage Flowr's cultivation expertise and our technical capabilities into real world testing and results that will make a difference to growers," said Chris Hagedorn, SVP & General Manager of Hawthorne Gardening. "We are proud of this collaboration with Flowr, a leading international cannabis company, with extensive growing experience indoors, in greenhouses and at-scale outdoors. Flowr is also one of a few companies that have had experience growing diverse genetics in different countries. We believe this experience will benefit our companies and the growers we serve."
"The completion of the R&D Center brings our work with Hawthorne fully to life and will help keep both companies on the leading edge of cannabis cultivation for years to come," commented Lance Emanuel, President and Interim Chief Executive Officer of Flowr. "Operationalizing the R&D Center is a major accomplishment for our organization and strengthens our competitive advantage in cultivation. We believe the long-term success of Flowr will be rooted in our ability to maximize the cannabinoid and terpene expression of genetics without sacrificing yield. The work we will do at the R&D Center will help us build upon the success we've had producing high quality, premium cannabis like our award-winning, flagship-strain BC Pink Kush beloved by budtenders and consumers throughout Canada. Leveraging our work at the R&D Center will be imperative to our eventual entry into the United States once federally permissible by law."
The R&D Center is the centerpiece of a strategic R&D partnership formed by Flowr and Hawthorne in March 2018. It brings two of the world's leading experts together to be at the forefront of cannabis cultivation. The operations will be led by Dr. Deron Caplan, the first person in North America to earn a PhD focused on cannabis cultivation and production. Dr. Caplan was awarded his doctorate by the University of Guelph in August 2018 and is Flowr's Director of Research and Development. The R&D Center will be staffed by Flowr's scientists, five of whom have PhDs in various plant biology, plant genetics and plant biochemistry disciplines. Hawthorne R&D will lead the research design and methodology.
All requisite licensing from Health Canada has been obtained by Flowr and the expectation is that the R&D Center will be operating at full capacity in Spring 2021. Research has already begun conducting growing trials at scale using Hawthorne products.
About Hawthorne Gardening Company
We know why you grow. And that influences everything we do. We are a company guided by a set of principles that motivate us every day. Hawthorne Gardening Company is built to serve growers of all sizes, from commercial cultivators to home hobbyists. We are made up of dozens of best-in-class brands, from Gavita, General Hydroponics and Sun System, to Botanicare and Mother Earth, that span every growing category from lighting to nutrients, growing environment, growing media, hardware, and many more. We drive bold research and development investments, unparalleled distribution capabilities and extensive service solutions that go far beyond product. And we use our voice to advance legislation that supports the responsible legalization of cannabis. Because our goal is to enable all growers to seize today's unprecedented opportunities and build the industry of tomorrow. Learn more at www.hawthorne-gardening.com .
About The Flowr Corporation
The Flowr Corporation is a Toronto-headquartered cannabis company with operations in Canada, Europe, and Australia. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility, an outdoor and greenhouse cultivation site, and a state-of-the-art R&D facility. From this campus, Flowr produces recreational and medicinal products. Internationally, Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in both Portugal and Australia.
Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products."
THE COMPANY COMPLETES ACQUISITION OF MAJOR SIGNIFICANCE! WE MUST WAIT FOR THE SUCCESSFUL PRODUCTION OF PSILOCYBIN WHICH WILL BE OF GREAT SIGNIFICANCE TO THE FUTURE OF THE COMPANY.
"Further to its press release of Dec. 24, 2020, Core One Labs Inc. has completed the acquisition of all of the outstanding share capital of Vocan Biotechnologies Inc., effective Dec. 31, 2020.
Vocan is a Canadian-based genetic engineering and biosynthesis research firm developing a proprietary low cost production method to biosynthesize GMP (good manufacturing practices) API-grade psilocybin. Utilizing a Health Canada-certified Controlled Drugs and Substances Dealer's Licence, Vocan's fully operational research laboratory in Victoria, BC is seeking to begin Stage 1 production in early 2021.
Vocan's mission is to use science and proprietary technology to advance the knowledge of natural-based medicines for the treatment of mental health illnesses, and addictions. Vocan's team of scientists, specializing in protein expression and biosynthetic fermentation, have discovered a patentable method of producing psilocybin, the active ingredient in psychotropic mushrooms. This technology will enable the production of GMP (good manufacturing practices) API-grade psilocybin, which can be used by pharmaceutical companies, API manufacturers and medical research organizations conducting clinical trials. Vocan's management expects that the unique optimized DNA (deoxyribonucleic acid) construct and producer strain will allow for efficient, cost-effective commercial scale production. Psilocybin production methods developed by Vocan's innovative technology will allow access to affordable GMP API-grade psilocybin.
Vocan's team of high-calibre scientists includes Dr. Robert E.W. Hancock OC, OBC, FRSC, a Canada Research Chair holder in Health and Genomics, a Director of the Centre for Microbial Diseases and Immunity Research and a holder of the Order of Canada for his contributions in these and other fields.
ACQUISITION PROVIDES CORE ONE LABS FULLY OPERATIONAL LABORATORY AND ACCESS TO CONTROLLED DRUGS AND SUBSTANCES DEALER'S LICENSE
The market for psychedelic derived medicines and therapies is estimated to be as high as USD$300 billion worldwide. Over the past decade, growing societal awareness and acceptance of mental disorders and addiction as real diseases has accelerated the push for new and innovative treatments using psychedelics, including psilocybin. According to a study published in the Journal of Clinical Psychiatry, treatment-resistant depression (TRD) cost employers upwards of $48 billion each year in the US alone.1 This cost is a result of direct increases in health care costs for the employer and both a decrease in productivity and an increase in absenteeism of employees who suffer from TRD. The potential for psilocybin products extends beyond just the existing market for anti- depressant drugs. Psilocybin has also demonstrated therapeutic benefits that ease existential anxiety in those with terminal diseases and alcoholism. Alcohol dependence places third in a list of preventable deaths in the US alone, costing the country $249 billion in 2010.
"The acquisition of Vocan gives the Company all the necessary licensing and research facilities to continue the development of psilocybin as an alternative therapy. Vocan's leading research team, led by Dr. Hancock, combined with its intellectual property to produce and patent biosynthesized API grade psilocybin, positions Core One as a leader in the psychedelic space. If Vocan can produce psilocybin at scale, it has the potential to provide products at a lower cost than every other company, disrupting the entire industry.
The addition of Vocan positions the Company as a vertically integrated industry leader, with production facilities, patient access and proprietary delivery methods," stated Joel Shacker CEO of the Company.
Transaction Structure
The Transaction was completed pursuant to a share purchase agreement among the Company, Vocan and the shareholders of Vocan (the "Definitive Agreement") dated December 23, 2020. Pursuant to the Definitive Agreement, and in consideration for the acquisition of Vocan, Core One issued (i) 23,500,000 common shares (the "Consideration Shares"); and (ii) 4,000,000 common share purchase warrants (the "Consideration Warrants") entitling the holders to acquire a further 4,000,000 common shares of Core One for $0.30 per share.
In addition to the Consideration Shares and the Consideration Warrants, the existing shareholders of Vocan are entitled to receive a bonus of up to 5,000,000 common shares of Core One (the "Bonus Shares"). The Bonus Shares will be issuable in two tranches, of which 2,500,000 will be issuable upon the successful synthesis of psilocybin, and a further 2,500,000 will be issuable upon the filing of a patent for such synthesis method in at least one jurisdiction.
The Consideration Shares are subject to a voluntary pooling agreement from which:
(a) ten (10%) percent will be released upon completion of the Transaction;
(b) a further fifteen (15%) percent will be released on April 31, 2021;
(c) a further fifteen (15%) percent will be released on June 30, 2021; and
(d) a further ten (10%) percent of the Consideration Shares will be released on July 31, 2021, and then a further ten (10%) percent on each successive
The Company is at arms-length from Vocan and its shareholders. The Transaction neither constitutes a fundamental change nor a change of business for the Company, nor has it resulted in a change of control of the Company within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. In connection with the completion of the Transaction, the Company has issued 235,000 common shares to an arms-length third-party who assisted with facilitating the Transaction.
About Core One Labs Inc.
Core One Labs Inc. is a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The Company has developed a patent pending thin film oral strip (the "technology") which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining excellent bioavailability. With this technology, the Company intends to further develop its IP technology to focus on delivering psychedelic molecules with an initial focus on psilocybin. Core One also holds an interest in walk-in medical clinics which maintain a database of over 200,000 patients combined. Through research and development in these clinics, including the integration of its intellectual property related to psychedelic treatments and novel drug therapies, the Company intends to work towards regulatory approval for research that advances psychedelic-derived treatments for mental health disorders."
NOT ONLY IS THE COMPANY RAISING SIGNIFICANT SUMS OF MONEY TO EXPAND PRODUCTION OF MARIJUANA, BUT MANAGEMENT IS TAKING SIGNIFICANT POSITIONS IN THE PP. ALWAYS AN ENCOURAGING SIGN!
"MPX International Corp., due to additional investor demand, has increased the amount of the previously announced non-brokered private placement offering of units of the corporation at a price of $1,360 ($1,000 (U.S.)) per unit to a maximum amount of $10.2-million ($7.5-million (U.S.)).
The corporation has issued a total of 5,000 units for aggregate gross proceeds of $10.03-million ($7,375,000 (U.S.)) from the closing of all tranches of the offering broken down as follows: first tranche which closed on June 30, 2020: 3,348 units for aggregate gross proceeds of $4,553,280 ($3,348,000 (U.S.)); second tranche which closed on July 31, 2020: 346 units for aggregate gross proceeds of $470,560 ($346,000 (U.S.)); third tranche which closed on Sept. 17, 2020: 800 units for aggregate gross proceeds of $1,088,000 ($800,000 (U.S.)); fourth tranche which closed on Oct. 20, 2020: 506 units for aggregate gross proceeds of $688,160 ($506,000 (U.S.)); fifth tranche which closed on Dec. 24, 2020: 2,229 units for aggregate gross proceeds of $3,031,440 ($2,229,000 (U.S.)); and sixth tranche which closed on Dec. 31, 2020: 146 units for aggregate proceeds of $198,560 ($146,000 (U.S.)). The corporation expects the remaining $170,000 ($125,000 (U.S.)) will close in early January, 2021.
The corporation intends to use the proceeds from the offering to finance product and facility development as well as for working capital and other general corporate purposes.
The units will be issued on the same terms as those previously announced at a price of $1,360 ($1,000 (U.S.)) per unit, with each unit consisting of one 12 per cent secured convertible debenture of the corporation in the principal amount of $1,360 ($1,000 (U.S.)) and 7,000 common share purchase warrants.
Each debenture shall bear interest at a rate of 12 per cent per annum from the date of issue, payable quarterly in arrears on the last day of March, June, September and December in each year. The amount of interest that becomes payable on the initial coupon date will represent accrued interest for the period from the applicable closing date to such initial coupon date. All accrued but unpaid interest as of each coupon date shall be payable by the corporation in cash and shall accrue interest at a rate of 12 per cent per annum. The principal amount shall be convertible, for no additional consideration, into common shares of the corporation at the option of the holder at any time prior to the earlier of: (i) 6 p.m. EST on the maturity date; or (ii) the business day immediately preceding the date specified by MPXI for redemption of the debentures at a conversion price equal to 12 cents per common share.
Each warrant entitles the holder thereof to purchase one common share at an exercise price of 20 cents for a period of 24 months from the closing date.
Insider participation
The fifth and sixth tranches of the offering can be considered a related party transaction for certain regulatory purposes. The participation by the insiders in the fifth and sixth tranches of the offering is summarized in the attached table.
Name Relationship to the Interest in the offering Common shares directly or Percentage of
corporation Amount $ Number of units indirectly, beneficially common shares of
owned or controlled MPXI
W. Scott Boyes Chairman, $6,800 (1) 5 4,655,350 3.28%
president, chief
executive officer
and a director
Alastair Director $282,880 (2) 208 8,134,472 5.73%
Crawford
Total $289,680 213 12,789,822 9.01%
(1) Mr. Boyes also participated in the second tranche of the offering acquiring 100 units for a subscription amount
of $136,000. In sum, Mr. Boyes has been issued a total of 105 units for an aggregate subscription amount
of $142,800.
(2) Mr. Crawford's participation in the fifth tranche of the offering was as follows: (a) 200 units issued to
Puddles 7 Ltd., a company in which Mr. Crawford holds a majority interest.
Mr. Crawford's participation in the sixth tranche of the offering is broken down as follows: (a) seven units issued to Mr. Crawford; and (b) one unit issued to Puddles 7. Mr. Crawford also participated in the second tranche of the offering acquiring 112 units for a subscription amount of $153,320 and the fourth tranche of the offering acquiring 136 units broken down as follows: (a) 86 units issued to Mr. Crawford; and (b) 50 units issued to Puddles 7. In sum, Mr. Crawford has been issued a total of 456 units for an aggregate subscription amount of $622,880.
It is important to note that the offering is exempt from valuation and minority approval requirements which might otherwise result from the participation by insiders due to: (1) the corporation, as a Canadian Securities Exchange issuer, not being listed on a designated market; and (2) the fair market value of the offering, insofar as the offering involves such interested parties, is less than $2.5-million.
To the knowledge of the corporation, after reasonable inquiry, none of the related parties have knowledge of any material information concerning the corporation or its securities that has not been generally disclosed.
A special committee of independent directors reviewed the offering, and determined that as a CSE issuer MPXI is not listed on a specified market and the fair market value of the offering, insofar as it involves related parties, is not more than $2.5-million. The special committee unanimously recommended that the board of directors of the corporation approve the offering. Accordingly, the offering is exempt from minority shareholder approval and formal valuation requirements of MI 61-101.
The offering is closing in less than 21 days due to the limited number of subscribers to the offering, all subscription agreements being properly completed and received, and all subscription proceeds having been forwarded, which shorter period is reasonable in the circumstances. MI 61-101 requires, if a material change report is filed less than 21 days before the expected date of the closing of the transaction, an explanation to be provided why the shorter period is reasonable or necessary in the circumstances.
The securities issued pursuant to the offering and the private placement have not been, and will not be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements.
About MPX International Corp.
MPX International is a multinational diversified cannabis company focused on developing and operating assets across the international cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient. With current operations spanning four continents in Canada, Switzerland, South Africa, Malta and Australia as well as evolving partnership and distribution opportunities in other jurisdictions, MPXI continues to position itself as an emergent global participant in the cannabis industry."
BY MY COUNT FLWR AFTER TAKEOVER HAS 315,088,688 SHARES OUTSTANDING SO ADDING ANOTHER 894,013shares IS HARDLY NOTICABLE!
But their revenue flows are going to have to be huge to justify share price appreciation.
" (“Flowr” or the “Company”) announces that it intends to satisfy the interest obligations in respect of its outstanding 10.0% subordinated secured convertible debentures (the “Debentures”) to be paid on December 31, 2020 (the “Interest Payment Date”) by issuing common shares of Flowr (“Common Shares”) to holders of Debentures in accordance with the terms of the indenture between the Company and Computershare Trust Company of Canada dated April 27, 2020, as amended.
As at the date hereof, there is $4,966,000 aggregate principal amount of Debentures outstanding and the aggregate accrued interest on such Debentures is $339,728 (the “InterestAmount”). Subject to approval of the TSX Venture Exchange, the Company intends to pay the Interest Amount on the Interest Payment Date by issuing an aggregate of 894,013 Common Shares at an issue price of $0.38 per Common Share, being the volume weighted average price of the Common Shares on the trading day prior to the Interest Payment Date.
About The Flowr Corporation
The Flowr Corporation is a Toronto-headquartered cannabis company with operations in Canada, Europe, and Australia. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility. From this campus, Flowr produces recreational and medicinal products. Internationally, Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in both Portugal and Australia. In 2020, Flowr’s BC Pink Kush was recognized as the top indica strain in Canada by kind magazine.
Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products.
AS ALWAYS, THE PARTICIPATION OF MANAGEMENT IN PARTICIPATING IN THE PP OF PGC should give shareholders confidence in the future of the company
"(“Plato” or the “Company”) announces the closing of the non-brokered private placement of 1,100,000 units (“Units”) at a price of CAN$0.05 per Unit for gross proceeds of $55,000, previously announced on November 3, 2020 (the “Offering”) and amended on November 24, 2020 and December 11, 2020.
Each Unit will consist of one (1) common share in the capital stock of Plato (“Common Share”) and one common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to purchase one Common Share at a price of CAN$0.10 per Common Share until the date which is thirty-six (36) months following the closing date of the Offering, whereupon the Warrants will expire.
The Corporation intends to use the net proceeds from the Offering to conduct drilling on the company's Holloway gold property, prepare the company's Lolita property in Santa Cruz, Argentina for an upcoming drill program, and general working capital purposes.
The participation in the Offering by James Cohen, and Anthony Cohen are “related party transactions” as such terms are defined by Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“), requiring the Corporation, in the absence of exemptions, to obtain a formal valuation for and minority shareholder approval of the “related party transactions”. The Corporation is relying on an exemption from the requirement to obtain formal valuation and minority shareholder approval as the fair market value of the participation in the Offering by the Insiders does not exceed 25% of the market capitalization of the Corporation, as determined in accordance with MI 61-101.
Completion of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange and applicable securities regulatory authorities."
INCREASED DILUTION OF SHARES OUTSTANDING BUT I GUESS IT REDUCES DEBT LOAD.
"The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announce it has completed the early conversion of certain of its 10.0% subordinated secured convertible debentures due April 27, 2024 (the “Debentures”) pursuant to the previously announced early conversion opportunity (the “Early Conversion Opportunity”). Approximately $16.4 million aggregate principal amount of Debentures were converted under the Early Conversion Opportunity, resulting in the issuance of approximately 47.8 million common shares of the Company. Upon closing of the Early Conversion Opportunity, there were approximately $5.1 million aggregate principal amount of Debentures still outstanding. All such outstanding Debentures will continue to be governed by the terms of the indenture between the Company and Computershare Trust Company of Canada dated April 27, 2020, as amended."
And now realism starts with KNR as reports of SALES start to come. Hopefully, the reports will become frequent and increased in volume in the coming weeks, months and years.
" ("Kontrol" or "Company"), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce a $750,000 order for its continuous emissions business which includes BioCloudTM units and a separate initial order from one of Ontario's largest Electricity Generators. The continuous emissions and BioCloud revenues are anticipated to be recorded in Q1 2021.
"We are very pleased to receive a significant order in our core business with a US manufacturing customer which also includes 2 BioCloud units as part of a package sale," says Paul Ghezzi, CEO of Kontrol. "Our corporate strategy is to quote BioCloud units as part of all new sales opportunities from our core business. In addition, we are pleased that one of Ontario's largest Electricity Generators has ordered an initial 2 units of BioCloud. Both customers have additional scale potential with numerous facilities. Our recent product launch and technology walk-through in December was a success and has initiated accelerating interest in how BioCloud can help create safer spaces."
Distribution Orders
To date the Company has received 40 initial distribution orders for delivery in January from its existing distribution network. The Company has entered into 6 distribution agreements (1 exclusive and 5 non-exclusive) and is in negotiations for various potential additional non-exclusive distributions agreements. Distribution is a key part of our go to market strategy that can allow the Company to scale quickly.
"In a short period of time since the official launch of BioCloud in December we have received strong interest and numerous distribution requests," says Gary Saunders, VP Kontrol. "We envision many more agreements across the globe as we focus on growing the BioCloud business."
As the Company continues to build its distribution business, we anticipate that distributors will be required to maintain a minimum of 250-unit sales per annum to retain non-exclusivity and distributor pricing. The Company's internal goal is to have 30 regional distributors established by the end of Q1 2021.
Customer Pilots
The Company plans to begin numerous pilots with both existing customers of Kontrol and new potential customers. The purpose of the pilots is to provide potential customers with various specific application use cases across their facilities. The types of pilot customers will include the sectors of commercial real-estate, grocery stores, franchised restaurants, educational facilities and other. Subject to pilot customer approval Kontrol may announce customer pilots or may operate them under non-disclosure agreement.
Recurring Revenue
The BioCloud unit operates with a proprietary detection chamber. The retail price for the detection chamber consumable will range from $400 to $500 and the recommended replacement is three times per year or whenever the detection chamber comes into contact with SARS-CoV-2. Customers that purchase multiple units will receive volume discounts for the detection chamber.
Re-Agent Supply Chain
The detection chamber includes a specific re-agent system. To date the Company has been sourcing its re-agents from the United States. The Company has initiated discussions and testing to source its re-agents from Canadian based sources. By doing so it is seeking to add more of its supply chain in Canada but also reduce the costs of the detection chamber. Further updates will be provided following additional testing.
Essential Service
Kontrol and its manufacturing supply chain operate as an Essential Service provider and do not anticipate being impacted by applicable COVID-19 shutdowns."
Management obviously paying more attention to trying to give more exposure to the Market of its progress in developing future revenue growth.
"("PLAN" or "Progressive Planet"), an emerging leader in the commercialization of natural pozzolans to reduce the carbon footprint of cement production, is pleased to announce that it has engaged The Howard Group Inc. (The Howard Group) as its investor relations communications advisor to direct both traditional and online initiatives targeting the investment community and retail investing groups.
The Agreement is for one-year commencing December 22, 2020. The total remuneration payable to The Howard Group will be $87,000 plus GST. In addition, The Howard Group will be granted options under PLAN's incentive stock option plan to acquire five hundred thousand (500,000) common shares of the Company with the exercise price equal to the closing price of PLAN's shares on December 23, 2020 or $0.10 per share, whichever is greater. These options have a term of three years and will vest quarterly over the one-year term.
The Howard Group Inc. is based out of Calgary, AB and its sole principal is Grant Howard. Neither the Howard Group or Grant Howard currently own any securities of Progressive Planet. The Howard Group intends to invest in 350,000 units of the hard dollar private placement announced by PLAN on December 21, 2020 for a total of $35,000.
The Agreement is subject to the approval of the TSX Venture Exchange.
Since 1988, The Howard Group has provided comprehensive investor outreach and capital markets programs, financing assistance, business development solutions and strategic planning to public companies.
In addition, The Howard Group will be providing an ongoing commentary on Progressive Planet's activities through its "Insight" blog. Interested parties are encouraged to subscribe to the commentary feed:
ABOUT PROGRESSIVE PLANET
Progressive Planet is an emerging leader in supplying solutions for a livable planet by developing low carbon, pozzolan-based, cementing products which replace equivalent amounts of Portland Cement and fly ash in concrete. The production of Portland Cement is the second largest global generator of CO2 emissions.
Progressive Planet operates its flagship Z1 Zeolite Quarry in Cache Creek, BC and is earning an 100% interest in the Z2 Natural Pozzolan Property near Falkland, BC and earning a 100% interest in the Heffley Creek Metals and Natural Pozzolan Property. All three properties are within a one-hour drive of Kamloops, BC, an industrial hub with rail access to Canadian and US markets."
/b]
PP announced to fund progress. Good to see management taking a good portion of the offering.
"("PLAN" or "Progressive Planet"), an emerging leader in the commercialization of natural pozzolans to reduce the carbon footprint of cement production, is pleased to announce two financings for aggregate gross proceeds of up to $550,000.
The first financing consists of a non-brokered private placement of up to 3,000,000 units at $0.10 per unit (the "hard dollar financing"), for gross proceeds of up to $300,000. Each such unit will consist of one share and one warrant exercisable at $0.15 per share for a period of 24 months from issuance. Use of proceeds will be for general working capital. Countryman Investments Ltd., a company of which David Richardson is the principal, intends to subscribe for 1,000,000 units in this placement. Mr. Richardson is a "control person" of the Company by reason of holding, directly and indirectly, more than 20% of the Company's current issued and outstanding shares.
The second financing consists of a non-brokered "flow-through" private placement of up to 2,500,000 units at $0.10 per flow through unit, for gross flow through proceeds of up to $250,000. Each flow through unit will consist of one "flow through" common share and one-half of a warrant, each whole warrant exercisable at $0.15 per share for a period of twelve months. Use of proceeds will be for continued exploration on the Company's 100% owned Heffley Creek Base – Precious Metal and Pozzolan Property in BC. A director of the Company intends to subscribe for 800,000 units of this flow through financing.
Eligible finders may receive a 5% cash finders' fee and 5% finder's fee warrants on the hard dollar financing only, subject to TSXV requirements. Finder's fee warrants will have an exercise period of 12 months, and an exercise price equal to $0.10 per share. There will be no finder's fees paid on the flow through financing.
All securities issued under these financings will be subject to a statutory four month hold period.
ABOUT PROGRESSIVE PLANET
Progressive Planet is an emerging leader in supplying solutions for a livable planet by developing low carbon, pozzolan-based, cementing products which replace equivalent amounts of Portland Cement and fly ash in concrete. The production of Portland Cement is the second largest global generator of CO2 emissions.
Progressive Planet operates its flagship Z1 Zeolite Quarry in Cache Creek, BC and is earning an 100% interest in the Z2 Natural Pozzolan Property near Falkland, BC and earning a 100% interest in the Heffley Creek Metals and Natural Pozzolan Property. All three properties are within a one-hour drive of Kamloops, BC, an industrial hub with rail access to Canadian and US markets."
Completion of takeover of Terrace Global another step in
FLWR management in adding cannabis production to increase revenue.
" ("Terrace Global" or the "Company") is pleased to announce that the Ontario Superior Court of Justice has issued a final order approving the previously announced plan of arrangement under the Business Corporations Act (Ontario) with The Flowr Corporation (TSXV: FLWR) ("Flowr"), pursuant to which Flowr will acquire all of the issued and outstanding common shares of Terrace Global (the "Arrangement").
In connection with closing of the Arrangement, trading in the common shares of Terrace Global ("Terrace Shares") on the TSX Venture Exchange ("TSXV") shall be halted as of noon on December 21, 2020.
In addition, certain directors and officers of Terrace Global have agreed to accept a portion of their change of control payments due upon completion of the Arrangement in Terrace Shares, which will result in Terrace Global issuing an aggregate of 3,346,613 Terrace Shares to such directors and officers at a deemed price of $0.2188 per Terrace Share concurrently with closing of the Arrangement. Each such Terrace Share will then be exchanged for 0.4973 of a common share of Flowr in accordance with the terms of the Arrangement.
Completion of the Arrangement is subject to certain closing conditions customary in transactions of this nature. Provided that all closing conditions are satisfied or waived, Terrace Global expects the Arrangement to be completed on or about December 22, 2020, following which the Terrace Shares will be de-listed from the TSXV.
About Terrace Global
Terrace Global is a multi-country operator (MCO) led by experienced cannabis entrepreneurs focused on the development and acquisition of international cannabis assets. Terrace Global's focus is on federally legal jurisdictions with existing domestic demand, low-cost inputs and approved for exportation."
THE TURN AROUND IN FLWR PROGRESS CONTINUES EVENTUALLY EARNINGS WILL JUSTIFY SIGNIFICANT IMPROVEMENT IN SHARE PRICES
" Canadian budtenders vote Flowr’s BC Pink Kush the Top Indica Flower in 2020.
Flowr’s BC Pink Kush was a top 10 selling SKU in the dried flower category and the #1 selling SKU in the premium dried flower category through Q3 2020 in Ontario.
Flowr’s BC Pink Kush has not been irradiated in approximately 2 years.
Flowr to move in 2021 to innovative packaging to highlight premium quality of its BC Pink Kush.
TORONTO, Dec. 18, 2020 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announce its BC Pink Kush was awarded the Top Indica Dried Flower in Canada. Chosen by over 150 retail budtenders from across the country, the awards were organized by kind Magazine, Canada’s pre-eminent premium cannabis lifestyle magazine. Budtenders voted on the best Canadian cannabis companies and products of the year across 22 categories and thousands of products.
“A recognition of this magnitude by budtenders across the country validates our strategy of becoming one of the leading companies in the premium segment of the cannabis market in Canada,” commented Vinay Tolia, Chief Executive Officer of Flowr. “Budtenders play a critical role in educating consumers about cannabis brands and products. We could not be more pleased to be viewed as having the best product in the marketplace by this key group of cannabis connoisseurs who act as Flowr brand advocates on our behalf.”
Josh Nagel, Chief Executive Officer of kind Magazine, shared his congratulations with the team at Flowr, “Congrats to the whole Flowr team on their kind award for 'Best Indica, Dried Flower' in Canada in 2020. There are a handful of LP’s that are so widely regarded by budtenders for quality and consistency and Flowr is clearly at the top of that list.” He continued, “Aside from their weed, there is a group of really really good, kind people behind the brand. Can’t wait to follow their success in 2021.”
This award comes after BC Pink Kush was a top 10 selling SKU in the dried flower category and the #1 selling SKU in the premium dried flower category through Q3 2020 in Ontario (1). Flowr believes a key differentiating factor with respect to its focus on growing quality cannabis is how its facility was designed to not use irradiation in its production process. Flowr’s BC Pink Kush has not been irradiated in approximately 2 years. Moreover, the Company believes narrow THC bands provide consumers with the consistency they expect from quality products and BC Pink Kush’s THC range has been 20-25% consistently over the same time frame. The aggregate list of winners is available in kind Magazine’s December 2020 publication which has an estimated circulation of 1.2 million readers.
In 2021, the Company will be implementing innovative new glass jars for its dried flower products. Flowr believes this packaging enhancement will build on its positioning within the premium segment of the market. The Company is also excited about upcoming new high THC cultivar launches in 2021 the first of which is expected to be BC Black Cherry which will initially be available in the market in pre-roll formats beginning in January 2021 with 3.5g jars to follow shortly thereafter.
(1) Source Hifyre data
About The Flowr Corporation
The Flowr Corporation is a Toronto-headquartered cannabis company with operations in Canada, Europe, and Australia. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility. From this campus, Flowr produces recreational and medicinal products. Internationally, Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in both Portugal and Australia.
Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products.
PLAN MANAGEMENT WITH POSITIVE NEWS UPDATE. SHOULDN'T BE
MISSED OVER THE WEEKEND
"("PLAN" or "Progressive Planet"), an emerging leader in the commercialization of natural pozzolans to reduce the carbon footprint of cement production, is pleased to announce that it has completed the 2020 Summer Exploration program with positive results on its 100% owned Heffley Creek Metals and Pozzolan Property in BC. PLAN has progressively reported through the summer of 2020 the results and discovery of a nickel and chromium soil anomalies, which were then confirmed by detailed rock sampling. The nickel and chromium anomalous area ranges from 150 to 300 metres in width and 600 to 800 metres in length (PLAN October 28, 2020).
The summer program consisted of soil sampling (459 soil samples), rock sampling (271 rock samples) and prospecting.
A total of 271 rock samples have submitted for analysis and all results have been received to date. Of the 271 samples, 84 (31%) returned values greater than 0.1% nickel and 43 (15.9%) of those samples returned values greater than 0.2% nickel, with the highest value being 0.27% nickel. The results are illustrated on Figure 1.
Of the 271 rock samples, 59 (21.8%) samples returned values greater than 0.2% chromium and 13 (4.8%) of those samples returned values greater than 0.4 % chromium with the highest values being 0.66% chromium. The results are illustrated on Figure 2.
Figures 1 and 2 illustrates the coincident anomalous nickel and chromium sample locations in an area ranging from 150 to 350 metres in width and 600 to 800 metres in length. The anomalous area is still open along strike to the south into an area of little outcrop. This anomalous trend is coincident with the previously identified nickel in soil anomaly reported on August 5, 2020.
The anomalous nickel and chromium grab samples were collected in altered leuco-gabbro and serpentinite rocks. There are 2 anomalous nickel – chromium samples (+ 0.1 % Ni and + 0.1% Cr) 500 metres to the south along this trend. The area between the 2 anomalous trends will be sampled in detail in the future, but with the lack of outcrop in this area and the beginning of snow fall at the high elevation of the area, this work will commence in the Spring of 2021.
All rock samples were also analyzed for gold. A total of 9 (3.3%) grab samples returned values over 0.1 g/t gold with the highest grab sample returned 0.6 g/t gold. Figure 3 illustrates the location of the anomalous gold samples within an area approximately 200 metres wide by 800 metres long with abundant quartz boulders and gabbroic bedrock with quartz stringers and veins. There is no correlation with gold and the nickel – chromium.
All samples are not necessarily representative of the mineralization hosted on the property.
Figure 1, 2 and 3 (CNW Group/Progressive Planet Solutions)
"I am very pleased with the results of the overall summer exploration program with the discovery of the nickel - chromium soil anomaly, then verifying the soil anomaly with rock sampling and then defining of the nickel – chromium anomaly in width and in length" indicated Dwayne Melrose, Director and Technical Advisor for PLAN. "There are still remaining identified nickel – chromium samples outside of the main anomalous area plus the elevated gold samples that have to be followed up in 2021. All data from the summer program will be complied and interpreted to define the 2021 summer exploration program."
"The discovery of anomalous chromium values of up to 0.66% in conjunction with the nickel values increases the value of the rock. Stainless steels contain at least 10.5% chromium, so there is a robust market for nickel and chromium. PLAN will begin the process of applying for a drill permit in January 2021," stated Steve Harpur, CEO.
As part of the check analysis program, 62 rock samples selected and were re-analyzed using Whole Rock Fusion/X-Ray Fluorescence Spectroscopy (XRF) at the ALS Canada metallurgical facility in Kamloops. XRF reported an increase of chromium content compared to the 4 acid digestion ICP that was initially used. To verify the chromium results and as a further check, all rock samples were then subjected to Whole Rock Fusion/X-Ray Fluorescence Spectroscopy (XRF) and conducted by ALS Canada Geochemical Division. The comparison of the XRF results with the original 62 XRF check samples have a very high repeatability. When comparing the two analytical methods for chromium results, the XRF values on average returned higher chromium values at an average ratio of 1.6 times. As the XRF method is a more precise method, all chromium results reported in this release and in the future will be based of the XRF analytical method.
Analyses were completed by the Metallurgical division and also the Geochemical division of ALS Canada. Base metal contents were measured by aqua-regia digestion and analysis on ICP-AES. The Precious Metals analyses were completed on all samples using fire assay fusion followed by AA finish (Au) or ICP finish (Pt and Pd) to measure gold, platinum, and palladium. Silver was measured using aqua regia digestion. All rock samples were also analyzed by 14 element Whole Rock Fusion/X-Ray Fluorescence Spectroscopy (XRF).
Dwayne Melrose, P. GEO, a qualified person for the purposes of National Instrument 43-101, has reviewed and approved the contents of this news release.
Update on Testing with University of Alberta
PLAN received written notification from the University of Alberta that due to access restrictions effective from December 14, 2020 through to a minimum of January 11, 2021, no testing work can be completed on the five tests which were contracted for completion with U of A as announced in a news release on August 20, 2020. "While this news is disappointing, we recognize that the safety of research staff is paramount during these unprecedent times. PLAN will evaluate other options to accelerate final testing of its PozGlass SCM product. PozGlass SCM was developed by PLAN to replace fly ash in concrete," stated Steve Harpur, CEO.
ABOUT PROGRESSIVE PLANET
Progressive Planet is an emerging leader in supplying solutions for a livable planet by developing low carbon, pozzolan-based, cementing products which replace equivalent amounts of Portland Cement and fly ash in concrete. The production of Portland Cement is the second largest global generator of CO2 emissions.
Progressive Planet operates its flagship Z1 Zeolite Quarry in Cache Creek, BC and is earning an 100% interest in the Z2 Natural Pozzolan Property near Falkland, BC and earning a 100% interest in the Heffley Creek Metals and Natural Pozzolan Property. All three properties are within a one-hour drive of Kamloops, BC, an industrial hub with rail access to Canadian and US markets.
This could be a major advance in FLWR moves in Europe which is best opportunity for growth at this time.
"THE FLOWR CORPORATION PROVIDES UPDATE ON EUROPEAN OPERATIONS
The Flowr Corp. has provide an operational update from its European operations which is jointly operated with Terrace Global Inc. In addition, Flowr announces a strategic warehousing agreement (the "Warehousing Agreement") with Tilray Inc. (NASDAQ: TLRY) ("Tilray") where the companies will take a collaborative approach to furthering their cannabis businesses in the European Union. The Company is also pleased to announce that the Company has agreed to close the final tranche of funding of the Aljustrel Joint Venture in the amount of C$1 million pursuant to the Equity Line and Profit Share Agreement (the "Agreement") with Terrace Global.
Operational Update
Flowr is pleased to report outdoor medical cannabis results in Aljustrel, where approximately 40,000 plants have yielded approximately 3,000 kgs of dried flower cannabis flower.
"Given the importance of Europe to the future of the cannabis industry and the historic United Nations vote we wanted to provide an update on our Portuguese operations. Since our partnership with Terrace Global began in May, 2020 we have been able to import a diverse set of high-THC genetics in Portugal, plant over 30 acres of outdoor medical cannabis and put in place the infrastructure that is anticipated to allow us to leverage over 180 acres of outdoor medical cannabis cultivation potential in the future," commented Vinay Tolia, CEO of Flowr. "There is no other project like this in the E.U. and we expect to be able to leverage this low-cost cultivation capacity to produce a diverse set of derivative products as well as dried flower which we believe will be released with GMP certification. We continue to work on closing the acquisition of Terrace Global by year end and are extremely excited by what the future holds for the combined organizations."
Recently, harvests from the Company's indoor polytunnels in Aljustrel have yielded approximately 35 kgs of 20% + THC cannabis dried flower which the Company expects to release with E.U. GMP certification in 2021. Additionally, and as previously announced, the Company's outdoor harvest yielded approximately 3,000 kgs of high THC dried flower cannabis flower.
"The preliminary results of the harvest from our polytunnels may be indicative of a successful business model in the E.U. medical cannabis industry. These lab results have shown the potential to cultivate high THC medical cannabis in polytunnels in a low-cost structure," commented Dr. Deron Caplan, Director, Research and Development.
During the summer, the Company focused its efforts on expanding its genetics library and currently maintains several high THC strains, including Sour-P, Black Dog, Brains Choice, Gelato, Gorilla Glue #4, and Green Doctor. Each of these strains tested between 18-23% THC.
Strategic Warehousing Agreement with Tilray
Flowr is pleased to announce a strategic warehousing agreement with Tilray whereby the parties have agreed to the storage and warehousing of E.U. GMP certified medical cannabis at the Company's Sintra facility in Portugal. The parties will undertake to develop a collaborative approach with a view to leverage each party's E.U. GMP certified facilities in Portugal to store and warehouse medicinal cannabis products for the European market. The commercial terms of the agreement were not disclosed.
Terrace Funding
As part of the Partnership and under the terms of the Agreement, Terrace Global has agreed to fund the operations and certain capital expenditures at the Company's outdoor facility located in Aljustrel, Portugal in exchange for common shares and warrants in Flowr. As part of the last tranche of funding, Flowr has issued to Terrace Global 1,923,077 common shares of the Company at a price of $0.52 and an equal amount of common share warrants. Each warrant is exercisable into one full common share in the capital of the Company at an exercise price of $0.76 per common share for a period of 36 months. The final tranche remains subject to the final approval of the TSX Venture Exchange. All securities issued under the final tranche are subject to the customary four-month hold period and may not be traded before April 15, 2020.
About The Flowr Corporation
The Flowr Corporation is a Toronto-headquartered cannabis company with operations in Canada, Europe, and Australia. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility. From this campus, Flowr produces recreational and medicinal products. Internationally, Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in both Portugal and Australia.
Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products."
And the growth continues! All we need is proof that revenue flow is positive from the additional population.
"(“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it is onboarding 15 new clients in Texas and Puerto Rico who will use its proprietary iUGO Care Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Behavioral Health Integration (BHI) and Telemedicine platform.
“We are very pleased to have added fifteen new clients to our customer base in Central and North Texas and Puerto Rico,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “These clients have over 12,000 eligible patients who will be using Reliq’s iUGO Care Software and Care Management services, at an average revenue of $65 USD per patient per month. We have already begun onboarding patients for these new clients and expect to complete the onboarding over the next 4 – 6 months. The new clients include physician practices, home health agencies and a Medical Clinic with over 10 locations between Dallas and San Antonio, Texas. Patient onboarding continues to accelerate, despite the holiday season and the worsening global pandemic. The Company remains on track to achieve cashflow positive in Calendar Q1 2021.”
Confirmation of the rumoured plans to uplist KNR! Welcomed
but management should be more careful in handling their activities.
("Kontrol" or "Company"), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce that it has completed its previously announced debenture exchange (see press release dated June 9, 2020 and November 2, 2020) by private placement. The 2020 Debenture holders exchanged a total of $3,650,000 for 2022 Debentures and new proceeds of $871,000 were raised. The remaining 2020 Debenture balance of $2,061,000 was redeemed in cash by the Company. Each unit is comprised of one $1,000 8% unsecured debenture (and non-convertible) of the Company maturing on October 31, 2022 and 10 common shares.
Paul Ghezzi, CEO of Kontrol, commented:
"With the exchange of the 2020 Debentures we have improved the balance sheet and the Company's net equity position. As we continue to execute on our business plan, we believe this is an opportune time to begin the graduation process to the senior North American exchanges for an uplisting in 2021."
Name Change
Further to the passing of a resolution of shareholders at its most recent general and special meeting of shareholders, the Company intends to proceed with a corporate name change to "Kontrol Technologies Corp.", which is anticipated to be completed prior to December 31, 2020.
Uplisting to TSX, NASDAQ
The Company's board of directors has authorized management to review the process to graduate the Company from the CSE to the TSX. If the Company is successful in uplisting to the TSX, Kontrol intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement with the Securities and Exchange Commission of the United States (the "SEC"), which will enable Kontrol to apply to be listed on the NASDAQ.
Completion of any uplisting is subject to meeting certain conditions, as well as the approval of the TSX. There is no assurance that the TSX will approve the listing application or that Kontrol will complete the uplisting as contemplated. There is no assurance that either the SEC or NASDAQ will approve the Company's respective applications or that Kontrol will complete the listing to the NASDAQ as proposed.
About Kontrol Energy
Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.
THE DIVIDEND IS PAID TODAY!!
("Newport" or "the Company") is pleased to announce the payment of its fourth quarterly cash dividend ("the Dividend") in 2020 of $0.03 per share to its shareholders of record at the close of business on November 26, 2020. As previously disclosed, the Company proposes to continue with the payment of quarterly dividend distributions, with the next payment scheduled for March, 2021.
Newport Exploration Ltd. logo (CNW Group/Newport Exploration Ltd.)
Annual Dividend and 2020 Share Price Performance
The $0.01/share dividend paid in September 2020 and the $0.03/share dividend paid today will be recorded in the Financial Year ended July 31, 2021, along with further dividends to be paid in early 2021. The Company's ability to return cash to shareholders is attributed to the recurring free cash flow generated by its Gross Overriding Royalty ("GOR") from licences in the Cooper Basin, Australia, operated by Beach Energy Ltd ("Beach").
Newport's dividend payout ratio, being the cash dividend per share of common stock divided by the earnings per share of common stock, compares favorably with that of other yield stocks, particularly those in the energy sector. Since 2015 the Company has paid an average Annual Yield of 21%.
With Beach's exploration success, reported oil reserves and low production costs, Management is confident that shareholders of the Company should continue to be rewarded with dividend continuity.
With respect to the Company's share price performance, Newport has been able to regain the lost ground from the March 2020 low and since mid-November has been trading at prices above the 2020 opening value, and at 6-year highs.
Investors are cautioned that historical results are no guarantee of future performance.
M&A activity has increased in 2020 as many companies facing liquidity pressures become forced sellers of assets. Management continues to evaluate opportunities that arise and are confident that if necessary, funds could be raised through equity financing, and most importantly for shareholders, without affecting the current dividend policy.
About Newport
Newport holds a 2.5% GOR on several oil and gas licences and permits in the Cooper Basin in Australia. These licences and permits are currently being operated and explored by Beach and Santos Ltd ("Santos"), both major Australian oil and gas producers.
The Company receives its GOR from Beach which is not a reporting issuer in Canada, therefore Newport is not able to confirm if the disclosure satisfies the requirements of NI 51-101 - Standards of Disclosure for Oil and Gas Activities, or other requirements of Canadian securities legislation.
The Company recommends that shareholders and potential investors access material information relevant to the Company as released independently by Beach and Santos in order to keep current during exploration, development and potential production of all the licences subject to the Company's GOR.
The Company currently has 105,579,874 common shares issued and outstanding and $5.8 million in the Treasury (comprised of cash, cash equivalents and short-term investments), and no debt."
MANAGEMENT DISCLOSING MORE EFFORTS TO REACH MARKETS FOR THEIR BIOCLOUD systems AID and better integration in their HVAC systems
" ("Kontrol" or "Company") is pleased to announce that it will be shipping a BioCloud unit to the United Arab Emirates for field demonstration during the week of December 13th. The demonstration is anticipated to run approximately 3 weeks.
"The planned shipment of the BioCloud unit to the UAE is based on regional interest in the application of viral detection technology," says Paul Ghezzi, CEO of Kontrol.
The Company is also pleased to announce that its BioCloud technology will be able to communicate in both modbus and bacnet protocols for integration into heating, cooling and ventilation systems (HVAC) for buildings. Modbus and bacnet are network protocols most commonly used for industrial automation systems and specifically for the connection and integration of electronic equipment. The Company has previously designed and incorporated modbus and bacnet protocols as part of its core energy management and air quality business operations. The software upgrade will be part of all future manufactured units.
"BioCloud will be able to operate as standalone unit or we can integrate with HVAC systems, as may be required, through this upgrade," says Gary Saunders, VP Kontrol.
About Kontrol BioCloudTM
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others."